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ABSTRACf
The immunization needs in Newfoundland and Labrador are currently met
through a mixed delivery system. Immunization is performed through the Regional
Health and Community Services offices. approximately 60"/0 and private practice
physicians., approlcimatcly 40"/0. This study assessed immunization practices in private
physicians' offices with a focus on storage, handling and documentation compared with
National Advisory Committee on Immunization (NACI) Guidelines. One of the key
aspects ofslorage and handling is the maintenance ofthe cold chain. The cold chain is
the process of maintaining vaccine at the optimum temperature from the time it is
manufactured until it is administered. Since the inception ofthe cold chain concept,
methods to assess and promote proper vaccine storage and handling have been
developed.
This study has a quasi-experimental. pre and post intervention design. The study
group consisted of solo and group private practice physicians who provide childhood
immunizations in urban and rural practices on lhe Avalon Peninsula in the Province of
Newfoundland and Labrador. Starting in March 1998, the researcher conlacted 37
offices representing 89 physicians to participate in the study.
The study consisted of an office visit during which information wu collected
concerning the practice for handling vaccine. This information was coUected through a
questionnaire, observa1.ion ofthe stoBge area and documentation ofthe refiigeruor
temperature. The intervention included the provision and discussion ofNational and
Provincial guidelines for storage and handling ofvaccine. A second visit six to eight
months later assessed change in practice post intervention.
Of the 37 available offices. 27 (73%) participated in the study representing 89
physicians; all offices visited met at least 18 ofthe 24 guidelines. Vaccine was stored in
the body of a refiigerator in 95% ofthe participating offices, 370/0 ofthe offices had a
thermometer in the refrigerator, and less than 2oo/" used thermal transport bags.
Documenting the refrigerator temperature on a regular basis was only done in one office.
Post intervention visits indicated little change in practice. This study has collected
baseline data about physicians' practices and has given some data as to what is effective
in encouraging physicians to maintain the cold chain.
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GLOSSARY
AntilCD - A substance (protein, polysaccharide, glycolipid, tissue transplant, etc.) that is
capable of inducing a specific immune response (Last, 1995).
Antibody - Protein molecule formed by exposure to a «foreign" substance, for example.
in inununization this "foreign" substance is a vaccine (Last, 1995).
Attack Rate - The cumulative incidence ofinfection in a group observed over a period
during an epidemic (Last. 1995).
Cold Chain - The process ofmaintaining vaccines at temperatures between 20 _ 80 C
from the manufacturer to the point of injection, through proper storage and handling
(Last. 1995).
Efficacy - The extent to which a specific intervention, procedure, regimen, or services
produces a beneficial result under ideal conditions (Last, 1995).
Herd immunity - Resistance ofa population to the invasion and spread ofan infectious
agent, based on the resistance to infection ofa high proportion ofindividual members of
the group (Benenson, 1995, p. 536). For example, in the case of measles, a very
infectious disease. the coverage rate must be very high (95%) to provide herd immunity.
To achieve such higlllevels, the vaccine must be at its optimum efficacy when it is given
(Benenson, 1995).
Immunization - Protection of susceptible individuals from communicable disease by
administration ofa living modified agent (e.g.Yellow Fever), a suspension oflcilled
organisms (e.g. pertussis), or an inactivated toxin (e.g. tetanus). This definition has been
xii
expanded in the 1980s and 1990s with the introduction of polysaccharide vaccines (e.g.
Haernophilus influenzae b) and genetically engineered vaccines (e.g. hepatitis B)
(Canadian lnununization Guide, 1998).
Temperature Moniton - Devices developed to monitor the temperature ofan enclosed
space over a specific period oftime.
Univenal Immunization Programs - Programs that are developed to provide vaccines
for a target group of people. For example, measles is a disease that has the greatest
morbidity and mortality in young children. Therefore, a universal immunization program
would vaccinate all young children, providing protection from disease to all members of
society (Last, 1995).
Surveillance - Surveillance is described as ''the continuing scrutiny of all aspects of
occurrence and spread of a disease that are pertinent to effective control" (Last, 1995, p.
163). Surveillance generates data which allows the measurement ofthe effectiveness of
a vaccine (Last, 1995).
Vaccine Refrigerator - A refrigerator supplied with electronically monitored
temperature controls.
xiii
LIST OF ABBREVIAnONS
LCDC - Laboratory Centre for Disease Control
WHO - World Health Organization
NACI - National Advisory Committee on Immunization
EPI - Expanded Program on Immunization
PAHO - Pan American Health Organization
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CHAPTERl
INTRODUCTION
In Newfoundland and Labrador childhood immunization programs are delivered
by physicians and public health nurses. The effectiveness ofthese programs is related to
the quality of the practice ofthose who implement them. The focus orthis study is the
storage and handling of vaccines by physicians on the Avalon Peninsula of
Newfoundland and Labrador. The storage and handling of vaccines were assessed
against national guidelines, and this study will provide data on these practices and their
compliance with national guidelines. The introduction will set a background by providing
an overview on the importance and the history of immunization and why storage and
handling of vaccines is an issue.
1.1 The Importance orVacdoalion Programs
The introduction of vaccines has had a dramatic impact on the healthofthe
world's population. Vaccines protect the individual from disease and, through universal
immunization programs, prevent the spread ofdisease (HilIeman, 1989; Levine et at,
1998). Since the 1800s morbidity and mortality resulting from infectious diseases have
decreased, as a result of immunization (Plotkin & Plotkin,. 1994). The decrease in disease
is evident when reviewing the epidemiology ofvaccine preventable diseases over the past
over the past 50 years. Several of the diseases which were common in early childhood.
including measles. mumps. rubella. diphtheria. tetanus and polio. are today seldom seen
in North America (MacDonald. 1998). For example. the epidemiology of measles bas
dr3marically changed since the introduction of measles vaccine in the early 1960s. lbis
decrease in morbidity is shown in Figure 1.1.
Figure 1.1 Reported cases of Measle.'l. Caoada, 1924 to 1996
Number of cases
100,000
".000
~ From Canadian Paediatric Society. (1998). Canadian National Repon on
Immunization,I997. Paediatrics and Child Health. 3 SuppB, 19B. Cases nor reported
between 1959 and 1968.
The decrease in morbidity is foUowed by a decrease in complications and
monality. This not only results in less human suffering but also in cost·savings (Casto &
Brunell. 1991). This key method of primary prevention is one of lhe most cost-effective
public health measures., as the cost ofthe disease and its complications is fM greater than
the cost ofuniversal immunization programs (Tengs et aI.• 1995).
1.2 An Historical Review orVaedoe Development
Edward Jenner developed the first vaccine in 1796. A rudimentary vaccine for
smallpox introduced a revolutionary concept ofdisease prevention. This process, known
as variolation, actually introduced dried pus from a human lesion caused by cowpox, a
virus closely related to the smallpox virus. into the patient (plotkin & Plotkin, 1994).
The medical community and the general public witnessed modified or less severe illness
in those who had been inununized (Levine et al., 1998). From the late 1870s through to
the early 1900s several others, including Roben Koch and Louis Pasteur, advanced
vaccine developmeD[ (plotkin & Plotkin, 1994). In 1885, Pasteur generated a live
attenuated vaccine for rabies, and this was the first laboratory developed vaccine. Killed
vaccines for typhoid. cholera and plague were developed in 1896 and 1897. Vaccines
for diphtheria, tetanus. pertussis and influenza were developed through the early 19OOs.
In 1945, the Government ofNewfoundland initialed its first childhood
immunization program. which protected against diphtheria and tetanus. One year later
the program was expanded to include the pertussis vaccine. During 1955. polio
vaccine was added to the schedule. These vaccines were provided with separate
injections with the exception ofpolio, which was a liquid, oral vaccine. A combined
vaccine was introduced in 1960 to protect against diphtheria and tetanus and pertussis.
The introduction of measles vaccine in 1965 was foUowed in 1971 with rubel.la vaccine.
By 1972, these vaccines were delivered as a combined vaccine, MR.. In 1974 mumps
was added to the MR. to create MMR (measles, mumps and rubeUa) vaccine which is still
in use in 2000. See Appendix A for a detailed history ofthe introduction of
immunization in Newfoundland and Labrador (R. Lewis, personal communication.
1998).
The trend to combine vaccines has continued as this method has lower delivery
costs and reduces trauma to the individual. The combined vaccines in use in
Newfoundland and Labrador at the time of this study include Pentacelnl and
MMR Ir"'. Pentacel "", which is given at ages two, four, six and 18 months, protects
against diphtheria. pertussis., tetanus, polio and haemophilus influenzae b. MMR II TM. is
ddivered at 12 and 18 months and protects against measles, mumps and rubella
(Department of Health and Community Services, 1997).
1.3 Why Proper Storage and Handling is Important
Two aspects of surveillance are vital in evaluating the effectiveness of an
immunization program: a) who is being immunized, and b) who is getting the disease? If
a person who has been immunized is getting the disease, why is this person suscepti'bl.e
after he/she has received the vaccine? Several studies have established that vaccine
failure is an issue (Hutchins et aI., 1990; Mast et aI., 1990), but few studies have
assessed the causes of the failure (Lerman & Gold, 1971; Krugman et aI., 1974).
Ground breaking studies, which are described in the Literature review, have established
that one ofthe more significant risk factors contributing to vaccine failure is a break in
the cold chain (Cheyne, 1989; Cheriyan, 1993).
The cold chain is the process of maintaining vaccines at temperatures between
20 _80 C from the manufacturer to the point ofinjeetion, through proper storage and
handling. The recommended temperature is the range that is suitable to penect viability
ofa specific vaccine. The cold chain is described by the World Health Organization
(WHO) as the "backbone" of immunization programs and is as much a concern in the
developed countries as it is in the developing countries (WHO, 1997).
The importance of proper storage and handling was stressed in Canada (Health
Canada, 1995) when guidelines for storage and handling ofvaccine were released. The
rationale for these guidelines was derived from studies that highlighted major deficiencies
in cold chain maintenance in Canada (Health Canada, 1995). The guidelines were
developed as a result of a coUaborative effort ofexperts in the field and then brought to
the National Immunization Conference participants in December 1994 for comments and
were released in June 1995 (see Appendix B).
An appreciation for the importance ofimmurux.uion and the realization that the
storage and handling ofvaccines should be an integral part of this process has led some
researchers to study the cold chain process. Since the late 19805 several studies (Bishai
et al., 1992; Casto & Brunell, 1991; Cheyne, 1989; Daniels & Naus, 1994) have assessed
various parts of the cold chain, especially how and why it may fail. To date, there have
not been any assessments of this kind done in Newfoundland and Labrador.
1.4 Purpose of the Study
The first purpose of this study is to assess the storage and handling practices of
vaccines in physicians' offices on the Avalon Peninsula of Newfoundland and the second
purpose is to see the effect of an intervention intended to improve this practice. It is
intended to promote improvement in compliance with the guidelines.
1.5 Hypothesis
Storage and handling practices of vaccines in physicians' offices do not
meet the recommended guidelines provided by the National Advisory Committee on
Immunizalion, specifically those guidelines that are appropriate in a physician practice
setting.
2. A planned intervention, provided through a personal visit., would improve
the vaccine storage and handling practices.
1.6 Researcll Objectives
The specific objectives ofthis study are:
To contact and request an interview with aU offices where physicians provide
childhood immunizations on the Avalon Peninsula.
To visit participating offices and complete a questionnaire and assessment of the
vaccine storage space.
To conduct an intervention with the person responsible for vaccine use in
panicipating offices and provide information on recommended storage and handling
of vaccines.
To revisit the participating offices and evaluate the effects of the intervention.
To compare the initial practices with the practice four to eight months post-
intervention.
To compare the assessed practice with the national guidelines established by the
Laboratory Centre for Disease Control in 1995.
CHAPTER 2
LITERATURE REVIEW
The literature review consists ofa summary ofthe available information on the
importance of immunization and the available studies on the assessment of the cold
chain. Several studies regarding broad·based immunization programming have been
cited in the introduction and will be reviewed briefly here. The topics involved in an
assessment ofthe cold chain are subdivided beginning with an initial section on vaccine
development. The second section provides an overview of the benefits of immunization
and the third the importance ofthe cold chain, including the link between the occurrence
of disease in immunized persons and improper storage and handling of vaccines.
Improving vaccine stability is the basis of section four. which is discussed as an option to
support, not to replace, the cold chain. The Canadian guidelines for storage and
handling and their development are discussed in section five and the literature review
closes with a section on physician compliance with the guidelines and peer review.
2.1 Vaccine Development
Vaccines provide protection from disease. and when administered to a person
who is non-immune,. the person's body responds to the vaccine by deve;Joping antibodies
to that particular disease (Levine et aI., 1998). The effectiveness ofimmtunization
depends upon the efficacy ofthe vaccine, how it has been stored, how ill has been
administered, and the level of protection it can provide. Infection occurning after
immunization is due to either primary or secondary vaccine failure. Prit:nary vaccine
failure is due to the lack ofseroconversion foUowing vaccination (Mast et al., 1990).
Serological evidence may wane but protective response remains. Secor-dary vaccine
failure can be described an initial protective respoMe, which wanes overr time. Either
type ofvaccine failure maybe the result of vaccine that is effective but does not give
lifelong immunity. This may occur with an improperly stored vaccine,. a.r it may occur as
a natural individual response (Krugman et aI., 1974; Lerman & Gold, I {.In I).
To ascertain that vaccines are efficacious a.'1d safe prior to Iicens:ing, they
undergo testing through clinical trials. A clinical trial is the process ofte=sting the efficacy
and safety of a drug, in this case vaccine, and providing data on how the optimum effect
can be reached (Levine et aI., 1998). Human clinical trials are specific in. testing for
safety, efficacy on the target group and efficacy in the population at larg,:e. For each
vaccine, the product monograph provides specific administration insttuc=tions for a
preferred site, dose by weight or age, route,. timing for a series and optirwtum storage
temperature. When all the conditions are met, a specific percentage oftltose immunized
should have protection from the disease. For example when all conditiolti are ideal the
expected response rate for measles vaccine is 95-97 % (Levine et aI., 19~8).
2.2 Benefib aDd Succeues orImmuDization
Immunization programs have frequently been cited as one ofthe best examples of
cost effective prevention programs. In Five-HundredUfe-&rving Interventions and
Their Cost-Effectiveness (Tengs et at, 1995), childhood immunizations rate as six of 56
items which have a less than or equal to zero cost for a life saved. The cost ofuniversal
immunization programs is minimal or less than the cost oftreating the disease and the
complications. There is no doubt that v:wcines prevent disease, morbidity and mortality
(Last. 1995; Plotkin & Plotkin, 1994).
There are about 50 vaccines in use today with the more common vaccines used
for universal childhood and adult immunization programs. The list of vaccine
preventable diseases is ever increasing. As new vaccines are developed they provide the
benefit of protection from disease morbidity and mortality that is highly cost effective
(Levineetal.,1998).
The World Health Organization has included the prevention ofcommunicable
diseases and immunization in its World Health Report since its inception in 1954 (WHO,
1998). In 1997 the Pan American Health Organization (PARO) celebrated the 20tll.
anniversary of its Expanded Program on Immunization (EPO in the Americas. This
program was developed to promote universal immunization programs, to promote
proper storage of vaccines used for childhood immunization, and to monitor
irr.munization rates. In !994 vaccines for six diseases (diphtheria, tetanus, pertussis,
polio, tuberculosis and measles) had been provided for 80"/0 ofchildren under one year
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ofage throughout the world (WHO, 1997). One of the latest accomplishments ofEPI is
the eradication of poliomyelitis from the Americas, which was achieved in 1991. and
certified in 1994 (WHO. 1997). Vaccination coverage rates for polio had increased from
20"/0 in 1977 to 80"/0 in 1997. This increase was achieved through ongoing universal
immunization programs and mass immunization campaigns which are known as National
Immunization Days (NIDs). A NID is designated as a day to provide vaccine to a
specific target group; for example. in December 1995 over a period of weeks, 82 million
children were immunized in India (WHO. 1997).
2.3 Cold Chain - A Vital Part of Immunizalion
Each year the WHO releases a report on the state of the world's health and
includes the rate of immunization coverage. immunization programs such as the polio
nationaJ immunization days, and storage issues. In 1997. the WHO pUblished .. The
State ofIhe World's Vaccines and ImmlmizaJion". This document gave details on
c!laUenges in providing vaccines, the specifics of the EPI. how vaccines are used world
wide. and the development of vaccines. The final chapter. "The Nuls and Bolls of
Immunization", provides complete details ofdelivery systems. how failures can occur.
and the importance ofthe cold chain in providing properly stored vaccines. Some ofthe
chaUenges to maintaining the cold chain include shipping to remote areas, a lack. of
electricity and refrigeration units.
With the development of the EPI program, the stability ofvaccines becomes an
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issue. Although the stability ofvaccines varies depending upon the antigen contained in
the vaccine. the detrimental effect offreezing on diphtheria, penussis and tetanus
vaccines and of heat on polio vaccine dictates the parameters for the cold chain. 1be
system of maintaining the temperature ofvaccines at 2°.8°C, or the cold chain, has a
vital role in providing vaccines that prevent disease (Bishai et aI., 1992; Briggs & nett,
1993; Casto & BruneU, 1991; Cheriyan, 1993; Cheyne, 1989; Levine et aI., 1998; WHO.
1997).
One of the first studies to question whether the storage of vaccines had any
possible link to disease in previously immunized children was undertaken in the early
1970s after an outbreak of measles in north-eastern Ohio (Lerman & Gold, 1971).
Fourteen children who had been immunized by one particular physician with live
attenuated measles virus vaccine had an attack rate of 17.9"10 compared with an attack
rate of 1.2% in 46 children who had been immunized by local public health authorities.
On further investigation, it was found that the measles vaccine had been stored in the
physician's office, on the inside ofthe door ofthe refrigerator where temperature
variations could occur with the opening and closing of the door. Measurements of the
temperatures of this physician's refrigerator showed minimums between 0°_2° C and
maximums between 6°.18° C. This was determined to be outside the acceptable range.
These findings suggest that vaccines, when not maintained at proper temperature
throughout the cold chain, might lose potency. While the authors recognized the
limitation that disease could not be directly linked to the loss of potency (resulting from
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incorrect storage), this raised awareness ofsuch. questions.
Others have tested vaccines from a controlled storage setting and th.en compared
these with vaccines which. h.ave had unknown storage conditions. In one study four live-
virus combination vaccines-measles, mumps, rubeUa, combined measles-rubella, and onll
polio-were used to test the relevance of improper handling on the potency ofth.e
vaccines (Krugman et aI., 1974). Vaccines in use in clinical practice were compared with.
a control vaccine, willch had been stored at the Bureau ofBiologics at 2<1-8<1 C in an
electronically monitored setting. After one year, the same lot of vaccine was recalled
from nine states where it had been stored in unknown conditions. The return of the
vaccine to the U.S. Bureau of Biologics occurred under proper 2<1_8° C, temperatures.
Findings indicated that 20 of the 107 samples (19"10) showed significant loss of potency;
this was extrapolated to reflect in the order of two standard deviations above or below
the recommended strength. Eighteen of the 20 samples had liule detectable virus, while
the remaining two had no virus, and therefore could have no effect in promoting
seroconversion. Tills work provided evidence that the potency of vaccines was affected
by improper storage and that storage in local physicians'offices was less than optimal.
Krugman's study did not have any data on the storage of vaccine in the community
during that year; therefore the vaccine mayor may not have been stored properly, The
study does provide infonnation on vaccine that had been stored in "typical" conditions.
While other studies discuss the outcome of measles outbreaks in previously
immunized populations, they do not look at why these populations remained susceptible
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post·immunization. Reimmunization with a second dose ofmeasles vaccine was
recommended. These studies focused on the modes of transmission and risk factors for
disease (Chen et al.,; 1989; Hutchins et aI., 1990).
1.4 Improving Vaccine Stability
In the late 1970s and throughout the 1980s vaccine stabilizers were developed
that increased the vaccine's effectiveness by reducing the risk of primary vaccine failure
due to improper storage and handling (Mast et aI., 1983). The introduction of stabilizers
to the vaccines provided products with a longer "shelflife". This may have created a
false reassurance that would be one of me reasons that concern for cold chain
maintenance was delayed in Canada until the 1980s. Obstacles and issues regarding heat
stabilization are the focus of work in the late 1980s (HiUeman, 1989). HiUeman's
research discusses obstacles to heat stabilization which include inherently unstable
polymers and the fact that the chemical structures are difficult to maintain except under
ideal conditions. This supports opting for the development of a cold chain, instead of
depending upon the development ofvaceine products with a broader range of stability.
Hilleman describes how changing the structure could affect the effectiveness of a
vaccine: "To be effective, these organic polymers must retain their primary and
secondary structures as well as their interrelationships if their activities are to be
retained" (p. 613). One limitation of Hilleman's study was that it assessed only one type
ofvaccine (measles. mumps and rubella), another was that the pharmaceutical company
14
which produces that particular vaccine released it.
I.S AJSessiDI tbe Cold Cbain Practices
The potency of vaccines is affected by exposure to too much heat. light or cold
(Lennan & Gold, 1971; Krugman ct al., 1974; Levine et a1., 1998). The cold chain., when
maintained, protects vaccines from these external factors and is described by the WHO
as the "backbone" ofthe EPI program and is as much a concern in the developed
countries as it is in the developing countries (WHO, 1997, p. 155).
By the mid-1980s the term cold chain had been used to define the proper
maintenance ofvaccines during the distribution process (Cheyne, 1989; Cheriyan, 1993).
This recommended standard of maintaining temperatures between 2 0_80 C was yet to
be assessed in practice. In 1989, Hunter's United Kingdom-based study assessed the
practice of nurses and physicians in storing and handling of vaccines. A questionnaire
was distribuled 10 all of the available 36 practices in south Hampshire and Dorset. and
included the foUowing questions: Do you keep a thennometer in your refrigerator?;
What type of refrigerator do you use?; What do you do with vaccines when you are
defrosting the refrigerator?; How long do you keep vials containing multiple doses of
vaccine? Do you give your patients vaccines to store at home? Nurses staffed many of
these practices and 33 of the 36 (92%) responses indicated that they did not know the
correct storage temperature and did not keep thermometers in their refrigerators. In
summary, "nurses cannot be sure whether the vaccines they use are potent and whether
they will provide adequate protection against life threatening diseases" (Hunter, 1989, p.
IS
66t). The author made recommendations for guidelines but no further follow up was
suggested, nor was a visit made to the offices to compare the actual practice with the
reported practice.
Other researchers in the United Kingdom assessed the quality of storage of
vaccines in the community (Thakker & Woods, 1992). In the Manchester Health
Authority region 45 offices were randomly selected and approached to participate in a
survey which questioned where tme vaccines were stored, who cared for the vaccines and
the availability of thermometers. afthe 40 (89% response rate) respondents, less than
half(16) were aware ofthe appraopriate storage conditions, eight had
maximum/minimum thermometers. but only one ofthese was monitored daily. This study
cited the lack of knowledge ofvaoecine care as a contributing factor to breaks in the cold
chain and expressed the need for BUidelines and the training of staff. Again one
limitation of this study was a lack offoUow up with the offices to promote proper
practice and to compare survey responses with actual practice.
Briggs & IDett (1993) in tile Central Birmingham Health District studied
transport temperatures. AU ofthe available 53 general practices and six health clinics
were requested to participate, anel 136 questionnaires were distributed and returned
(1000/0 response rate). Vaccines 'o;l(Cre tagged with a Monitor Mack Time-Temperature
Integrator Tag (T"'3-M) and a questionnaire was enclosed. This tag monitored the
temperature during transport oftbe vaccines and at the destination provided a record of
the length oftinIe the product was exposed to the recommended temperatures. The
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questionnaire provided infonnation on the mode oftransport, journey time and distance
and whether remgeration was available during the transport as weU as inunediately upon
delivery. Ofthe responses received, 104 of the 136 (76%) indicated that transport
conditions were suboptimal. Most (82%) shipments by car were not remgerated and
(68%) did not refrigerate the vaccines on arrival. Several ofthe areas assessed indicated
points where the cold chain had not been maintained during the transportation phase.
These areas included cars without a coldbox, journeys in 21°C temperature and a lack of
remgeration upon arrival. This study did provide exact data on the temperature of
vaccines during a two-week period.
By the early I990s more work was done in the United States to promote the
importance of the cold chain. It had been recognized and recommended that: "One
important factor that can affect vaccine efficacy, however, is rarely discussed-how
vaccines are handled during shipment and storage" (Casto & Brunell, 1991, p. 108).
This paper provides an overview of the importance of the cold chain and the long-tenn
ramifications should vaccine be improperly stored:
Inactivation of a vaccine may become apparent only after patients
who are administered the product acquire the disease it was designed
to prevent. Even when this happens, it is likely that the identified
cases will be considered primary or secondary vaccines failures, and
the role that improper vaccine handling may have played in the failure
will escape scrutiny (p. 108).
The authors support adherence to the cold chain as one way of ensuring that
vaccines with the expected potency wiU reach the target population.
A report on paediatricians' offices in Los Angeles was completed in 1992.
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Forty-six primaly care paediatricians were randomly selected as weU as three university-
affiliated hospital.based clinics and one community clinic for a sample size of50. A
telephone call was made to each office to request an office visit to assess the storage of
vaccines. The participation rate for this study is not provided. A summary of results
indicated that vaccines were routinely stored outside the refiigerator and stored in
uninsulated containers during the practice day, ''vaccine storage errors occur in
paediatric offices at an unacceptably high frequency" (Bishai et al., 1992, p. 193). Only
16% of vaccine storage co-ordinators could cite appropriate temperatures and 18% were
unaware that heat could harm vaccines. Temperatures were checked weekly in only
20"10 of the practices and vaccines were routinely stored outside refiigerators in 16%.
The report concluded that paedialricians should "familiarise themselves with guidelines
for optimal vaccine storage in order to minimize the potential for vaccine failure in
primary care practice" (Bishai et al., 1992, p.193). The authors acknowledged that the
limited number ofavailable offices made it difficult to generalize the results but that ''the
high prevalence ofavoidable vaccine storage errors were striking" (p. 194).
In another leading paper, Cheyne (1989) described a hypothetical journey of
vaccines for the typical 12 to 18 month voyage of vaccines from production to delivery.
The premise was that the vaccines are at the greatest risk as it leaves the main offices and
travels out to the community, where several opponunities arise for interruption ofthe
cold chain. Cheyne identified some experiences of loss of vaccine potency that
potentially occur during the transport period including a delay ofa day or two on an
18
international flight, delays at customs and so on. In tropical countries. the lack. of ice
making capability is an issue. Cheyne suggested that by identifying the weak spots in the
cold chain, countries or private sector manufacturers can develop strategies to avoid
these occurrences.
As recently as 1999 assessments ofthe cold chain practices have been completed
in the United Kingdom (FlJUl & Crook, 1999). In this study a total of 107
questionnaires were sent (anonymously) to general practices in the United Kingdom
known to employ one or more nurses, and resulted in 7S responses (73%). This
questionnaire assessed vaccine handling and storage in general practices. [n all but one
the response came from the nurses; the exception came from a receptionist. Sixty-three
of the 7S stated that the nurses were responsible for vaccine management. Over half of
the practices used domestic refrigerators instead of the recommended vaccine
refrigerator. Only 27 of the 1S offices used thermometers, yet SS reported monitoring
the temperature prior to an immunization session. Finn and Crook concluded that "in
this particular health district, maintenance ofthe cold chain is not always accorded the
degree of care necessary for safe practice" (p.41). The areas of particular concern
included receipt and storage of vaccines, temperature monitoring control, management
of vaccines during immunization sessions and disposal of partly used vaccines. The
survey response was not verified by an office visit and this led to a caution regarding
storage of vaccines from the authors.
One ofthe earliest Canadian studies (Steinmetz et al., 1981) questioned the
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storage of live measles vaccine. Measles vaccine had been introduced in Canada in 1963,
and a 9QO/o reduction in the incidence of cases was subsequently reported. Outbreaks in
1979 and 1980 led to concern about the effectiveness ofthe vaccine when a survey
showed that 60% of the 260 cases had been previously immunized with measles vaccine.
Had illness occurred as a result ofimproper vaccine storage? In 1981, twenty
immunization centres were visited without notice, including 13 paediatricians associated
with the Montreal Children's Hospital, six inununization clinics and one hospital clinic.
These offices were randomly chosen from a list of paediatrician's offices. The vaccine
and the refrigerator temperatures were measured with specific attention to the placement
ofvaceine in the refrigerator. In 17 of the 20 (85%) practices studied, the vaccine had
been stored at temperature levels above the recommended safety limit (Steinmetz et al.,
1983). Other problems included vaccines stored in the freezer with no power back up,
and vaccines left unrefrigerated for several hours at a time. The vaccines tested were the
newer heat stabilized vaccines and no significant loss of potency was noted when the
components were tested. This study questioned whether the lack of proper storage and
handling in the past may have affected the less stable vaccines produced and used prior
to 1979. Ifthis were the case, improper storage and handling may have played a
significant role in the 1979 and 1980 outbreak of measles.
FoUowing these concerns, Daniels and Naus (1994) performed an evaluation of
the cold chain in Ontario. Their study took the form ofsurveys and visits to audit
storage practice in physicians' practices. The survey revealed that 31% of physicians'
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refrigerators had temperatures outside of 2° _8° C range. Daniels and Naus also found
that 20"/0 ofthe vaccine refrigerators were over 10 years old and unreliable. Less than
15% ofthe refrigerators used a thennometer and fewer than 22% of couriers transported
vaccine in insulated containers (Daniels & Naus, 1994). These cold chain concerns led
to a formal cold chain evaluation. This study used temperature monitors., which indicate
exposure to temperatures above 12°C. These Monitor Marks® were attached to 80
DPT (diphtheria, pertussis, tetanus) and polio vaccine packages distributed from the
Ontario Public Health Vaccine Depot. The recipients were requested to telephone a toU
free number on the following occasions: when the vaccine was received, if the vaccine
changed clinics, when all the doses were used, and ifany colour change in the cold chain
monitors was noted.
A total of76 (88%) cold chain breaks occurred during the distribution
process with 98% of the breaks taking place during storage at health
departments, physician's offices or clinics. Only 2% took place during
transpon. This was higher than the previously reported study in
Durham where 57% of packages were heat exposed (Daniels & Naus,
1994, p. 99).
Daniels and Naus concluded that education ofphysicians was needed to improve
vaccine storage and handling. As a result or this study, an education program for
physicians was initiated. The program included an extensive information package on
proper storage and handling, how and where to order a maximum-minimum
thermometer, and established a telephone line for questions. In 1998, preliminary results
of a foUow.up study showed a vast improvement in vaccine storage post-education and
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provision ofthennometers (T. Deasey, personal communication, 1998).
British Columbia is the only other province that has assessed storage of vaccines
in public health and physicians' practices. PieJak et al. (1995) descnbed a survey of94
physicians and 22 public health offices. While exact numbers were not presented. the
summary concluded that few vaccines are properly transported and stored. This led to
an awareness program for health· professionals who immunize. No subsequent studies
have followed the infonnation campaign to date, but personal communication with staff
in this division indicate a positive response from vaccine providers (K. Pielak. personal
communication, 1997).
Other concems about deterioration ofvaccines from improper storage and
handling recently came from Australia. Gold, Kemp and Osboume (1998), in a letter to
the editor of The Australian Medical Ioumal. raise concerns that while many initiatives
to increase coverage rates exist. "few vaccine providers adhere to a cold chain storage,
and a recent study from a metropolitan area in Australia has documented that vaccines
are often subject to temperatures below freezing points"
(p. 471). The unpublished studies referred to in this letter had led to the conclusion that
the burden ofillness increases with the susceptibility that occurs from the use of vaccines
that have lost their potency. This in tum has implications for the lost income of parents
or caregivers and additional costs incurred as a result ofhospitalization for
complications. This letter to the editor emphasized the continued concern for lack of
proper storage and handling.
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Most of the evidence that suggests that improper storage and handling ofvaccine
is a factor in the susceptibility of previously vaccinated individuals is indirect. The
studies that support this theory are those which have indicated that there is loss of
potency in vaccines that have been exposed outside the recommended 2°_So C
temperature range.
In 1992 a study was initiated in British Columbia to test the effects offreezing on
DPT or OPT-inactivated poliovirus vaccines and to determine if a previously used
"shake test" could accurately identifY vaccines that had been previously frozen. Forty
single dose vials were divided: five were used as controls and stored at 2°_SoC. 20 were
placed in a freezer set at ·10° C. the final 15 vials were set at a temperature of
- 70° C. The control vials remained unchanged in colour and viscosity. Those vials
exposed to _10° and ·70°C temperatures were not visibly altered. The shake test could
not be used to detennine whether or not vaccines had been exposed to freezing. The
recommendation from this study was that "The only reliable means to determine if
vaccines have been inadvertently frozen and thawed is to place temperature monitoring
devices beside them during transport" (Dimayuga,. 1995, p. 102). A similar study
(Brazeau & Delisle, 1993) reported on experiments which indicated a loss of potency in
previously frozen vaccine. These studies were referenced in the development ofthe
National Guidelines for Vaccine Storage and Handling in Canada.
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2.6 GliideliDes for VacciDe Stonlge aDd HaDdling in CaDada
In 1995. the National Advisory Committee on Immunization (NACI) released iu
Guidelinesfor Vaccine Storage and Transportation. The Canadian Pediatric Society,
the Laboratory Centre for Disease Control and the Bureau ofCommunicable Disease
Epidemiology endorsed these recommendations. Portions of these recommendations
were published in 1995 in the Canadian Medical Association Journal and the Canadian
Family Physician. In the /996 Newfoundland and Labrador Communicable Disease
Report, the national guidelines were adapted and printed as recommendations for vaccine
storage and handling. In December 1997. NACI released its recommendations for
Childhood Immunizations. These guidelines were summarized in the February 1997
Canadian Medical Association News issue, with a statement endorsing the immunization
guidelines (Canadian Medical Association, 1997) and recommended that physicians
foUow NACI's guidelines for vaccine storage and the recording and reporting of
childhood immunizations.
These guidelines were developed "as a genera! guide for consideration" (Health
Canada. 1995, p. 93) and bringing them into practice would depend upon each province
and territoI)'. The Childhood Immunization Division, Bureau ofCommunicable Disease
Epidemiology, Laboratory Centre for Disease Control, undertook. the preparation ofthe
guidelines for vaccine storage and transport in collaboration with a group ofexpert
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advisors. The documents used in preparation ofthe guidelines included:
- Compendium ofPharmaceuticals and Specialties. (29111 cd.) Canadian Pharmaceutical
Association, 1994.
- Product Infonnation Sheets, 1993/94. (10" cd,) WHOIUNICEF Technical Series,
May 1993.
- World Health Organization cold chain information: publications, instructional slide
sets,. and training courses.
- Vaccine Distribution, Storage and Handling Guidelines. Mandatory Health Programs
and Services, Public Health Branch, Ontario Ministry ofHcalth. Draft Copy,
September 1994.
2.7 Physician Compliance with Guidelines and Peer Review
Physician compliance with guidelines has often been low; yet guidelines and
standards for practice are the nonn (Studiciki et al., 1993; Goethe et aI., 1997). How
then can physicians be encouraged to follow guidelines? While this question was not an
original part oflhis research, the results from physician interviews provided some insight
into this area. Arifet al. (1998) evaluated physician compliance with tuberculosis
treatment standards lhrough a chan review in Pakistan in 1995. A questionnaire to
evaluate physician compliance was developed, pilot tested and standardized. A chart
review was conducted of all patients hospitalized with tuberculosis comparing diagnosis
and treatment with the WHO standards. The researchers concluded that physician
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practice "reflects poor awareness ofthe WHO guidelines with low compliance among
physicians" ( Arif et al., p. 230).
Lawler and Viviani (1997) went a step further to assess why compliance is low in
the treatment ofdiabetes in the United States. Interviews were conducted with 295
patients with diabetes and their respective physicians. Their findings indicated that
physician beliefs and practices varied greatly and provider performance ofthe national
standards for diabetes care was low. The most common factors for this included a lack
ofknowledge. implementation problems. a lack of belief in guidelines, and problems with
patient compliance.
In responding to physician non-eompliance. some research has suggested that
computer generated reminders were effective in promoting discussion of patient care
(Dexter et al.• 1998). Peer review was also an effective method ofencouraging
compliance (Grol et aI .• 1988; Lang. 1991).
Peer review of physicians' practice is the "review ofclinical performance, when it
is a form of medical audit" (Last, 1995. p. 123). Expectations ofpeet" review include
providing indicators for uniformity in practice and. at the same time, assisting in the
development of general practice medicine (Grol et aI., 1988). Peer review that included
assessment of the cold chain was developed in Atlantic Canada in the early 199Os. This
program was based on a similar program in Ontario which has been in place since 1981
(NLMA. 1991), and which provides an assessment ofa physician's practices by other
physicians. ''This involves one or two physicians visiting an office and looking at such
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things as legibility of charts, function ofequipment, cleanliness and so on" (NLMA,
1991. p. I). As peer review developed, specific topics were submitted for review. In
1993 the first group ofassessments was completed (mcluding storage and handling of
vaccines). This involuntary process began with (ow numbers and has gradually
inCTeased, with 90 assessments completed in 1995. In the Newfoundland and Labrador
Medical Association Newsletter-NLMA Communique (AprillMay, 1999), the
refrigeration of vaccines and drugs is listed as one of the "deficiencies that directly affect
patient care" (p. 13). The results of the assessments are not provided but it includes a
statement about the importance of refrigeration and documentation of refrigerator
temperature for the proper care ofvaccines.
2.8 Assessing the Vaedne Distribution System in Newfoundland and 1.lIbrador
in Relation to the Cold Chain
Maintaining appropriate storage and handling at a set temperature (usually 2°_8°
C) from the time the vaccine leaves the producer until it is administered is known as the
cold chain. To assess the cold chain in this study, one must first understand the process
for distribution of vaccines to and within Newfoundland and Labrador. Public Health
Nurses, with the exception of the Avalon Peninsula where public health nurses (6QO/o)
and physicians (40"/0) provide the service almost exclusively provide childhood
immunization programs in Newfoundland and Labrador. Typically in rural areas, public
health nurses provide the service through child health clinics. In the urban areas.
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physicians and public health nurses provide vaccines in their respective offices. On the
Avalon Peninsula 89 physicians in 37 offices provide childhood vaccines, of which the
most conunon are MMR (measles, mumps and rubella) and DaPTPlHib (diphtheria,
acellular pertussis, tetanus, polio and haemophilus influenzae b). The process for
distribution ofvaccines in Newfoundland and Labrador is as foUows(R. Lewis, personal
conununication, lanuaIY, 1997}:
I. Suppliers send vaccine, under monitored storage conditions, to the provincial
vaccine distribution depot in St. lohn's. The province's Department ofHealth
and Conununity Services purchase this vaccine for the immunization
programs.
2. Cold storage is maintained in temperature controlled refrigeralors with alarm
systems in place.
3. Monthly vaccine orders are filled from the depot and forwarded in labelled,
Styrofoam containers with ice packs and temperature monitors to the Health
and Conununity Services office in each of the six regions in the province.
4. On its arrival, infonned staff, who have been trained in the importance of
maintaining the optimal temperature, receive the vaccines. Packing slips with
temperature monitors are contained in each vaccine shipment and the
temperature is verified on receipt. This packing slip is then returned to the
provincial office to ensure that all shipments have reached the regional office
with the cold chain maintained.
s. The regional Health and Community Services office supplies district public
health offices with vaccine using Styrofoam boxes or thetrnai bags with ice
packs. Physicians typically pick up their vaccine from the Health and
Community Services office staff in paper bags or a courier ships them to the
physicians' offices in a cooler equipped with ice packs.
2.
6. In physicians' offices. household type refrigerators are used for storage.
A break in the cold chain may occur at any point., but the weakest link in the
chain occurs when the vaccine leaves the regional office for the district office and from
the district office to the physicians' offices. Health and Conununity Services offices use
the guidelines outlined by the Provincia/Immunization Manua/, first issued in 1988.
Physicians are notified through newsletters, letters from the locai Medical Officer of
Health, and through the Newfoundland and Labrador Medical Board on the proper
storage and handling ofvaccines (A. Roberts; R. Young, penonal conununication,
February, 1998).
2.9 Pilot Study
The investigator conducted a pilot study in 1997 in preparation for this research.
A 22.question survey was developed 10 assess the practice of storage and handling in
public health and physicians' offices and provided an opportunity to pre-test the
questionnaire. Questionnaires were mailed to 25 public health nurses and 2S physicians
in the St. JOM's area from a listing provided by the Health and Conununity Services
office. This questionnaire was intended to gather infonnation on who was inununizing
and how vaccines were being handled. The questionnaire included questions on
demographics. on years in practice, the number ofinununizations given in a week, where
the vaccine was stored, whether the temperature was documented and how the vaccine
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was transported when it left the refrigerator.
More than 22 ofthe 2S (88%) public health nurses responded to the
questionnaire. Furthcnnore all ofthese respondents indicated storage and handling of
vaccines which adhered to 22 ofthe 24 (92%) guidelines (O'Keefe, 1997, unpublished).
Refrigerator storage was maintained with thennometers in place, although not all of
these thennometers were maximum/minimum. The refrigerator temperatures were not
being monitored nor were water bottles used to help maintain the refrigerator
temperature. These measures were implemented to some degree shortly thereafter (M.
Mayo, personal conununicatiOI1, 1997). Water bottles were installed, and monitoring
and documentation on a twice·a·week basis was initiated. Insulated bags were used for
the transport of vaccines to satellite clinics and a visit to these offices confirmed proper
methods for storage as weU as monitoring ofrefiigerator temperatures.
Only six of the 2S (24%) physicians responded to the questionnaire. Of the six
returned questionnaires, only two were fully completed. Ofthe completed questionnaires
the documentation of temperature was non~existent;some responses had question marks
(?) placed next to a question regarding the Canadian Guide 10 Immunization, querying
what this was, and when asked how vaccine was transported, the response was always in
a paper bag. The responses regarding storage and handling of vaccines in physicians'
offices indicated that further research was needed in this area.
1.10 Summary
30
The importance of maintaining the cold chain is a vital part ofan effective
immunization program. In short, there has been no lad ofeducational materials
provided for nurses and physicians in support ofproper immunization techniques,
including the cold chain as indicated in the documents sent to health care professionals
after the national guidelines were published in 1995. Much ofthe research to date
strongly suggests that improper storage and handling ofvaccines in physicians' offices is
an issue which may contribute to health problems. Discussion with Medical Officers of
Health for Newfoundland and Labrador and the provincial Director ofDisease Control
and Epidemiology supported a study to assess the storage practices in physicians'
offices. To date no other studies on vaccine storage and handling have been carried out
in Newfoundland and Labrador.
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CHAPTER 3
METHODOLOGY
nus chapter includes a description oCthe design. measures. and ethical
considerations ofWs study. which has a quasi-experimental, pre- and post· intervention
design. It was carried out over a period of IS months, from February 1998 to May
1999. The sampling frame consisted ofall urban and rural physicians who provide
childhood immunizations and have offices on the Avalon Peninsula in the Province of
Newfoundland and Labrador.
3.1 Design
In designing this study several authorities were consulted for input on the
questionnaire, consent form and methods. These authorities included the College of
Family Physicians. Newfoundland and Labrador Medical Board, Newfoundland and
Labrador Medical Association and Health and Community Services offices in the St.
John's and Eastern Regions. These groups were contacted to investigate whether past
studies had been completed in Newfoundland and Labrador. No research had been done
in Newfoundland and Labrador.
The pilot project in 1997, described in the Iiternture review, was conducted
involving a mail-out questionnaire. The poor response rate (24%) from the maiJ-out to
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physician offices was a deciding factor in detennining the choice of the methods for this
study. An office visit would increase participation and was therefore the method of
choice for data coUection.
The questionnaire was developed using varied sources (Briggs & lien. 1993; T.
Deasey, personal conununication, 1997; Haworth et aI., 1993; Hunter, 1989; Thakker &
Woods. 1992). A similar questionnaire (see Appendix D) had been used in Ontario
(Daniels & Naus, 1994); portions ofthis were used (f. Deasey. personal communication,
February, 1997). The National Guidelinesfor Storage and Handling ofVaccine
(Health Canada, 1995) provided 35 guidelines ofwhich 24 were chosen as appropriate
for practice in a physician's office. The briefquestionnaire was designed to be completed
in the short period of time pennined in the physician's office.
The first phase of the study involved a pre.arranged, in-office visit with an
opportunity to obtain consent to participate in this study, assess the vaccine storage area
and complete the questionnaire. At the end of the first visit the intervention package was
provided (see Appendix G) and a discussion of what changes might be required to better
meet the guidelines (e.g., obtaining a thermometer and where) was undertaken. The
second phase ofthe study was an unannounced visit six: to eight months later to assess
any changes since the first visit. This visit was an observation ofthe storage area and did
not require the physician's presence.
3.1 Subjects
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The areas served by the Health and Community Services in St. lohn's and
Eastern Newfoundland were chosen because in these areas the physicians provide
childhood immunizations. In rural Newfoundland and Labrador community health
nurses provide an estimated 95% ofchildhood immunizations (Department ofHealth and
Community Services, personal communication, 1997). A listing ofthe physicians who
are given vaccine to provide childhood immunizations was obtained from the Health and
Community Services offices in the St. John's and Eastern Regions. The list from the St.
John's and Eastern Health and Community Services offices consisted of37 offices
representing 89 physicians; these were contacted beginning March 1998. All of these
offices were on the Avalon Peninsula, which is the most populated area ofthe province
with one-third of the total population according to the 1996 Census (Statistics Canada,
1996).
3.3 Instrumcnt
The questionnaire consisted ofthree distinct sections (sec Appendix C): the first
provided demographic information; the second questioned general storage issues
including the type of storage; and the third was complctcd through observation and
measurement. These questions had been developed using the national guidelines as the
"gold standard" (Health Canada., 1995).
These national guidelines provide)5 recommendations which, iffollowed, would
allow for proper maintenance ofthe cold chain in vaccine storage. These are subdivided
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into three headings: Knowledge and Responsibility for Vaccine Care; Storage of
Vaccines in Physician Offices; and Temperature ofVaceine Refrigerators and
Documentation ofRefiigerator Temperatures. The recommendations for storage, wilich
are applicable in a physician's office, are summarized in Tables 3.1-3.3. These tables
provide II commentary on the method ofassessing each ofthe guidelines (column 2) in
the questioMaire (see Appendix C). One question regarding the availability of freezers
was not a national guideline, but was added as this data would be of particular interest in
the event that a vaccine required freezing (Nationallmmunization Conference, 1996).
The content of the questioMaire was developed using a similar questioMaire used in
Ontario (see appendix D) and several studies conducted in the United Kingdom (Briggs
& lllen, 1993; Haworth et al., 1993; Hunter, 1989; Thakker& Woods. 1992). Validity
of the questionnaire was obtained through peer review, review by the Medical Officers of
Health and through the pilot test conducted in 1997.
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T.ble 3.1 Assessment ofKnowledce .nd Responsibility for V.ccine Cue
Guidelinc Method of Assessment
Onc person in thc practice should be responsible for vaccincs Questioned
All persons responsiblc for handling vaccines should know Questioned
The correct storage tcmperatures; should be trained in this
Power failure procedure should be posted on the door, ObselVed
And this should be foUowed in such an event
Educational matcrial should be availablc on thc cold chain Questioned
In all centres where vaccine is stored
Procedures for "exposed" vaccine should be in place Questioned
Regular maintenance ofrefrigerators should be Questioned
Performed and records kept
Vaccine Associated Advcrse Event forms should be Questioned
Completed as required
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Table 3.2 Storage or Vaccine ia Pbysicians' Offices
Guideline Method of Assessment
Vaccine should be stored in the main part (body)
Of the refrigerator. never on the door
Vaccines should be refrigerated as soon as
Possible after transport
Refrigerator should be dedicated to vaccine storage only
Defrost ifmore than one centimeter of ice has accumulated
Vaccines should remain refrigerated except when in use
Space should be left between vaccines to aUow circulation
Ofair
Keep a sign near the electrical plug to prevent accidental
Loss of power
Make sure the door is closed when not in use
Adsorbed vaccines should be stored well away from
Ice or possibility offreezing
Vaccine should be transported in insulated containers
With appropriate freezer paclcs
Water bottles should be used as a temperature stabilizer
In the refiigerator
Observed
Questioned
Observed
0 •..-
Questioned
Observed
Observed
Questioned
Questioned
Observed
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Table 3.3: Temperature of Refrigerators and ()o(:umentation ofTempera.ture
All refrigerators should have a
Maximum-minimum thermometer
Two daily readings of the refrigerator temperature
Should be taken and recorded on a regul~ basis·
The temperature oCthe storage refrigerator
Should be between 2 0_ SoC
Immunization should be recorded on the patient's chart
Immunization should be recorded and given to the
Patient or parent
A record of immunization should be forwarded 10
the Health and Community Services office
Questioned & Observed
Questioned & Observed
Observed
Questioned
Questioned
Questioned
·"Regular" basis would be defined as once a week to twice a month.
Recommendations in the national guidelines for transport applied mainly to large
quantities of vaccines, such as shipments from manufacturers. The recommendation that
vaccines should be transported in an insulated container, with an appropriate number of
ice packs, was appropriate for physicians' offices and was questioned in the study.
A search ofthe literature and discussion with experts in the field led to one
questionnaire that had been used in Ontario; no others could be located. Results of the
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studies often provided a summary ofthe topics covered and provided the type of
appropriate questions (Briggs & IDett, 1993; Haworth et aI., 1993; Hunter, 1989;
Thakker& Woods, 1992). The questionnaire used in this study, along with the content
of questions and expected responses, was developed using The Canadian Guide to
Immunization and the Guidelines/or Storage and Handling (1995) and the
questionnaire used in Ontario (see Appendix D). The pilot study had included a pre-test
of the instrument used in this study and was used with minimal modifications,. which met
the requirements ofthe study and the Human Investigations Committee of Memorial
University ofNewfoundland.
The 22 questions were "Yes or No" (10), multiple choice responses (11) shon
answer (1) and an opponunity for comments at the end (see Appendix C). There was
time at the end of the interview for an opportunity to discuss and clarifY issues. The
questionnaire covered demographics. key responsibility for the care of vaccines, storage
and handling practices, and comments regarding the current system for distribution. The
visit also included measuring the refrigerator temperature, observing the storage area,
and providing answers to several spontaneous questions asked by the physicians and not
queried in the formal ponion ofthe questionnaire.
The second phase of the study included an unannounced visit six to eight months
after the initial visit. The practices were again be assessed regarding storage and
handling of vaccine with panicular attention to the areas found deficient in the first visit.
As consent for this visit had been signed during the first visit no prior notification was
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necessary. The post-intervention or second phase visit took approximately ten minutes
with questions focusing on changes in the practice. The refrigerator was observed for
the deficiencies evident in the first visit, such as the availability of a thermometer,
documentation of the refrigerator temperature, and the presence of water bottles.
3.4 Permission and Informed Consent
An initial telephone contact was made for the physicians' pennission to conduct
an interview in their office. Panicipation in this study was voluntary.
The first item of the interview was the informed consent form (see Appendix E).
This form eJq)lained the nature, purpose and objectives of the study, was witnessed and
dated by the office secretary. This consent to participate in the study included the initial
visit on that day and the unannounced visit planned for Phase II four to eight months
Ia.ter.
3.5 Conridentiality
To maintain confidentiality, each two-page questionnaire was coded to
correspond to the informed consent form. The consent form and the completed
questionnaires were kept in separate files. Only one identifYing factor was used 10
indicate if the participant was from a rural or an urban setting, which was required as
part of the analysis. This information was kept in a locked drawer with identifYing codes
kept in a separate place. Only the investigator had access to the codes.
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3.6 Risks lind Benefits
The only risk to physicians, as a group, was the possible discipline that would
result from the disclosure of poor handling. Through the confidentiality agreement no
single practice would be identified in the results. Discipline would not come from the
investigator but could come with the release of the results. The consent fonn included II
statement which confinned that the information gathered would be used solely for
research purposes.
Possible benefits evidenced throughout the study included information for the
panicipating physicians' offices on proper storage and handling and had the potential to
improve the CUfTent practice, as weU as an opportunity to discuss vaccine storage and
handling.
3.7 Data Collection
3.7-1 Procedure for Pha:se I
A letter ofintroduction (see Appendix F), which was sent from the Medical
Officers ofHealth in the St. John's and Eastern regions to all possible participants gave a
brief description of the study and identified the investigator. The first telephone contact
with each office was within two weeks ofthe sending ofthe introductory letter. A copy
of the letter was also taken to the interview in the event that verification was required.
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A total of40 offices were contacted by telephone. Telephone protocol (see
Appendix H) was used during the telephone call to ensure consistency among the
participants. The office secretary took the call and then consulted with the doctor before
an appointment was made. Two offices no longer provided childhood inununizations and
one office had closed before the telephone contact was made, leaving a total of37
possible offices ofthe 40 first identified.
Ifaccepted, an office interview was lUl1Ulged during the telephone call and visits
were made at the convenience of the office. Most often these were held at the beginning
or end of the practice day or at lunchtime. Many offices had one physician or office
manager who was responsible for the vaccines. The interview was conducted with that
physician or manager as the representative ofthat practice.
Appointments were made one week to one month in advance. Several offices
were busy and requested a call at a later date. These returned phone calls carried on into
May, June and July, 1998. Phase I interviews took place from April (998 to July 1998,
typically with a duration of 10 to IS minutes, and included:
Explanation of the project and the signing of the informed consent
Completion of the questionnaire
General discussion around the care of vaccines
Intervention package of information on vaccine storage and handling (see Appendix
G)
Measurement of the refiigerator temperature and the observation of the vaccine
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storage area
3.7-2 Procedure for Phase n
The second visit was to assess any change in the practice of vaccine care since
the initial visit. To allow the office sufficient time to obtain any necessary equipment, the
investigator waited for six to eight months after the initial visit before the second visit.
The questions asked during the second interview revolved around the same general
points as the first interview with an added focus on the key points notably absent in
Phase L Observations of the storage area were also made at this time and included:
Presence ofa thermometer
Presence of documentation chart for refrigerator temperature
Presence ofwater bottles
Position of the vaccine in the refrigerator (should be central and space for air
circulation)
Phase n was completed in two parts: the first from October to November 1998,
and the second from January to March 1999. The second visit was conducted with the
office staff, in particular the office manager or the person who ordered the vaccine and
was responsible for vaccines, not the physician. Only those offices that had participated
in Phase 1 were visited in Phase II.
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3.8 Data Analysis
The data from the questionnaire were analyzed using EPI-INFO; version 6,
(1994) for frequencies and proportions to provide a description ofthe study population.
Comments and discussion ofconunon themes and topics were analyzed by coding
responses into categories. for example, the reason for obtaining a thermometer or
comments on the present system for distribution.
Content analysis of the open·ended questions and comments were used to
identifY recurrent themes. Conunents and topics from discussions were grouped and are
also compared in relation to vaccine care. Cross tabulations were conducted with the
data for comparison of setting (urban or rural (outside the municipal boundaries orSt.
}ohn's!Mount Pearl», number ofyears in practice. whether an office was group or solo.
A group practice is one with two to six physicians sharing an office and the same storage
facilities for the vaccine. All of the physicians in a group used lhe vaccine that was
stored in the same office refrigerator. A solo practice is one where the physician works
alone). The final demographic infonnation collected was the gender of the physician (or
the physician who immunized in rnal office) completing the questionnaire.
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CHAPTER 4
RESULTS
The results will be presented in five sections. First the chamcteristics of the study
population will be reviewed for participation and demographics. This will be followed
by findings from each ofthe areas assessed: a) Knowledge and ResponSIbility, b) Storage
of Vaccine and c) Temperature and Documentation. As described in the methods
section, these areas represent the national guidelines for storage and handling. Finally
there will be a section on temperature and a summary of guideline compliance.
4.1 Participation
The populations available are those physicians who provide childhood
immunization on the Avalon Peninsula. This study represents the majority of physicians
who provide childhood immunizations in the province ofNewfoundland and Labrador.
The participation rate ofthe study was 73% (27137) offices and 75% (67/89) orall the
physicians who provide childhood immunizations on the Avalon Peninsula. Tables 4.1
and 4.2 provide an overview of the participation by the number of offices. number of
physicians, practice type, and geographic location.
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Table 4.1 Participation by Number or orraces and by Practice Type and
Location
Type of practice Rural(%) Urban ("/a) Total ("/0)
n=13 "-24 n=-37
Solo 6 (46%) 2 (8%) 8 (22%)
Group 6 (46%) 13 (54%) 19 (51%)
TotaJ participating 12 (92%) 15 (63%) 21 (73%)
TotaJrefused 1 (8%) 9 (38%) 10 (27%)
n - number of offices
Table 4.2 Participation by Number or Physicians and by Practice Type and
Location
Type of practice Rural(%) Urban(%) Total (%)
n=30 n=59 n=89
Solo 6 (20%) 3 (5%) 9 (10%)
Group 23 (11%) 35 (59%) 58 (65%)
TotaJ participating 29 (97%) 38 (64%) 61 (75%)
Total refused 1 (3%) 21 (36%) 22 (25%)
n ... number of physicians
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Contacting the office and arranging the office interview took varying lengths of
time. The number ofcalls to set up a visit ranged from two to six. calls with the average
fourca1ls.
In the Nral offices, an equal number (6) of solo and group practices was visited.
The group practices in the lIUrai areas represented 23 physicians and there were six solo
practices, for a total of29 (97%) of the available physicians captured. In the urban area
the participation rate was lower at 64%. In St. John's, 35 of the physicians who
participated were in group Jlractices and 3 in solo practices. There were more than twice
as many group practices co-mpared to solo practices. Ofthe ten offices that refused to
participate there were two :solo and eight group practices. One (8%) rural office refused
while 9 (38%) urban offices refused.
When a telephone c:aU was made, it was left to the secretary to decide whether or
not the request was brough;a to the physician. Two ofthe secretaries in the urban area
responded: "I can check for: you but Dr. - does not do that sort of thing". In these cases
the physicians may have been approached, but participation was denied. This limitation
was addressed with subsequent telephone calls and in some cases speaking with the
physician; this resulted in olrle visit that had been denied previously. Solo practices in
both urban and rural generaJIy responded that it was impossible to participate, as heJshe
was the only person in the clinic. The most common reason given for not participating-
"the office is too busy" - caJIlle from four of the ten offices (40'%); two stated that they
did not participate in surveys and the remaining four did not give a reason for their non-
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participation.
4.2 Demographics
In this section infonnation was coUected on sex, the number oryears in practice
and number of immunizations given in the average week by the physicians in that
practice. In each practice one person was responsible for vaccine care; this person
completed the interview. In two offices the person responsible was an office manager,
and in the remaining 2S offices it was a physician. The office managers provided
information for the physicians who gave the most childhood immunizations in that office.
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Table 4.3 Demographic Features of PbysiciaaJ ResponJible for Vaccines and
Number of Vaccines Administered in a Week
Rural (0/0) Urban(%) Total(%)
0=12 0=15 N=27
S"" MoJ. 9 (75%) 6 (40%) 15 (56%)
Female 3 (25%) 9 (60"/0) (44%)
Years in Practice
<1
1-9 2 (17%) 4 (27%) 6 (22%)
10-19 6 (50%) 8(53%) 14 (52%)
20-29 4 (33%) 3 (20%) 7 (26%)
Average number of vaccines given in a week per physician on average in a practice
1-4 6 (50%) 7 (47%) 13 (48%)
5-9 2 (17%)
10-14 2 (17%)
>15 2 (17%)
4 (27"/0)
) (20%)
1(7%)
6 (2%)
5 (19%)
3 (11%)
Of all the physicians' males and females were almost equally represented, 12
(44%) females and 15 (55%) males. All participants had more than one year of
experience. with the majority having greater than ten years experience (78%). Twenty-
two percent of the physicians interviewed had one to nine years' experience.
The physician or office manager who was interviewed was asked how many
immunizations were provided. on average, in a week. The numberofimmunizations
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carried out by physicians in a week was relatively low with almost half(48%) providing
from one to four immunizations in the average week. All of the solo practices, regardless
of urban or rural, perfonned only one to four immunizations a week. Two of the solo
offices reported that they provided only ten immunizations a year. Twenty·rwo percent
gave five to nine immunizations a week. 19"/0 ten to fourteen and only 3 group offices
(11%) gave IS or more a week.
4.3 Storage and Handliog Practices. Phase [
Tables 4.4 through to 4.8 provide an overview ofthe National Advisory
Committee Guideline recommendations and demonstrate how actual practices compared
with the ideal. For example. in regard to the guideline that one person is responsible for
vaccine care, 25 of the offices had designated such a person. These tables are structured
to the divisions of knowledge and responsibility, storage and temperature and
documentation.
'0
Table ..... Results of Knowledce and Responsibility Questions
Guideline
One person in the practice should be responsible for vaccines
All persons responsible for handling vaccines should be trained
And know proper vaccine care
Power failure procedure should be posted on the door, and
This should be followed in such an event
Educational material should be available on the cold chain
In aU centres where vaccine is stored
Procedures for "exposed" vaccine should be in place
Refrigerators repaired as required
Vaccine Associated Adverse Event forms should be completed
Practice met guideline
(%)
OP27
25(93%)
21 (78%)
2(7"/0)
27(100"/0)
25(93%)
27 (100010)
N/A
Twenty-6ve of the 27 (93%) offices had a designated person responsible for
vaccine care. Not all persons were aware ofthe correct refrigerator temperature. When
provided with three temperature options only 21 of the 27 (78%) chose the correct
option, 2°_ 8° C. Two offices (7%) had power failure procedures in place, two others
had them but they were not posted. Similarly, no procedures for handling "exposed"
vaccine were observed but 25 (93%) offices reported that they had them in place. All
offices had educational material of some type on hand, including the Canadian
Immunization Guide (in three offices this was an old edition), newsletter information
from the Department ofHealth or the Health and Community Services office. All offices
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responded that they were content with the system for distribution ofvaccines and knew
whom to call ifproblems aro.\oe. One frequent comment was that the fonn used to report
inununizations to the Health and Conununity Services offices was "cumbersome".
When the investigator questioned the physician about the Vaccine Associated
Adverse Events fonn (see Appendix I) the response was that they had not required one
as adverse events were infrequent. If they did have opportunity to report an adverse
event. this would be by a telephone call to the local Medical Officer ofHealth in the
Health and Community Services office.
"
Table 4.5: Results orStorage orVa«iae Questions and OmenatioDs
Guideline Practice met guideline
rP27(%)
Vaccine should be stored in the main part (body)
ofthe refrigerator, never on the door
Vaccines should be refiigerated as soon as possible
after transport
Refrigerator should be dedicated to vaccine storage only
Freezer available
Defrost ifmore than one centimeter of ice has accumulated
Vaccines should remain refiigerated except when in use
Space should be left between vaccines to allow circulation
of air
Keep a sign near the electrical plug to prevent accidental
loss of power
Make sure the door is closed when not in use
Adsorbed vaccines should be stored weU away from
ice or possibility offreezing
Vaccine should be transported in insulated containers
with appropriate freezer packs
Water bottles should be used as a temperature stabilizer
in the refrigerator
27(100"/0)
27(100%)
26 (96%)
3(11%)
3 of3 with freezers
27(100%)
25(93%)
0(0"/0)
27 (1000/0)
26(96%)
4(15%)
1(4%)
Many of the vaccine storage issues were observed while the storage space was
being assessed and the temperature of the refiigerator taken. In all practices vaccine was
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stored in the refrigerator. The refrigerator door was not used for storage, and air was
allowed to circulate around the vaccines. When asked about the procedure enforced
upon receipt of vaccines, each office stated that the vaccines were immediately
refrigerated. Only three ofthe practices had refrigerators with freezers. While this is not
a guideline, it was assessed in the interest offuture products. particularly varicella
vaccine, which must be maintained at .200 C. Of the other 24 offices, one had a full-
size, one--door model refrigerator which had the freezer companment removed (because
it was not used). Of these 24, 23 had half-size remgerators without a freezer
compartment. Only one office had water bottles at the top, bottom and sides to act as a
temperature stabilizer in the event of a power loss. This item was the most commonly
deficient.
Vaccine was transported in a thermal bag or in a cooler in four rural practices
(15%). Those offices within a five-to ten~minute drive felt that a paper bag was
sufficient to maintain the 2°· 8° C and the offices stated that that was how the regional
depot had provided the vaccine.
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Table 4.6 Results of Temperature and Documentation QUestiODS aDd
Observations
Guideline Practice met guideline
n=27 (%)
All refiigerators should have a maximum-minimum
Thennometer
Two daily readings ofthe refiigerator temperature
should be taken and recorded
The temperature of the storage refrigerator should be
between 2° - 8 °C
Immunization should be recorded on the patient's chart
Immunization should be recorded and given to
the patient or parent
A record ofimrnunization should be forwarded to the
Health and Community Services office
to (37"/0)
1(4%)
24 (89%)
27 (100%)
26 (96%)
25 (93%)
While ten of the offices had thermometers, onJy eight documented the
[emperature ofthe refrigerator where vaccines are stored on a regular basis. None
of the practices documented the temperature of the refiigerator on a twice-daily
basis, as per the recommendations.
The recording of immunization includes: Vaccine type, lot number,
dosage, site where the vaccine is given. the date administered and a record of
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immunization given to the individual who has been immunized. All of the offices
questioned responded thal they rea:m:led immunization infonnation on the chart, and
all but one office gave a record to the patient and aU but two forwarded a record to
the local Health and Community Services office.
Table 4.7 Temperatures iq Refrigerators
Temperature in degrees Centigrade
" 27
No. of practices (0/00)
1(4%)
3(11%)
5 (19"/a)
8(30%)
6(22%)
2(7%)
2(7%)
The correct temperature of the refrigeralor where vaccine was stored,
between 2°· 8° C, was recorded in 89% of the physicians' offices. In two ofthe
urban and one oCthe rural physicians' offices. the lemperatures were outside the
range of 2°· 8° C.
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Table 4.8 Number of practices and location by number of guiddidts
m<t
Number of guidelines C'/A) met of24
Questioned or observed
24 (IOO%)
23 (96%)
22 (92%)
21 (88%)
20 (83%)
19 (79%)
18 (75%)
Uroan
n=14
Ru.-.l
n=IJ
Total
n=27(%}
1 (3.7%)
1 (3.7'1.)
2 (7%)
8 (29.6%)
7 (25.9%)
7 (25.9%)
1(3.1%)
In summary, only onc office met all ofthe 24 guidelines, one met 23 ofthe 24
and 2 met 22 of the 24. The majority (81%) ofthe offices met between 19 to 21
(79-83%) of the 24 guidelines. The guidelines that were most commonly
51
deficient in Phase I included:
The power failure procedure was not posted on the door in 22 oCthe
27 offices, (92% were deficient in the initial visit).
• The vaccines were not transported in insulated containers with
appropriate freezer packs in only 23 ofthe 27 offices, (85% were
deficient in the initial visit).
Water bottles were not used as a temperature stabilizer in the
refrigerator in 26 of the 27 offices, (96% were deficient in the initial
visit).
Maximum-minimum thermometers were not used in 17 of the 27
refrigerators. (63% were deficient in the initial visit).
Two daily readings of the refrigerator temperature were not taken in
26 ofthe 27 offices, (96% were deficient in the initial visit).
4.4 Results ofPbase 0
Phase two of the project was completed four to eight months after the
initial visit. The 27 offices that had participated in Phase I of the study were the
focus ofPhase II. These offices were visited unannounced and the storage and
handling practices again assessed. with a specific focus on the areas found to be
deficient in the initial visit.
"
The offices that used thennometers as well as had the proper storage
and handling procedures in the initial visit still had the same procedures in place
in the Phase II visit. The most notable change that had occurred after the initial
visit and intervention was that eight ofthe 17 offices, which did not have a
thennometer in the initial visit., had obtained one by the second visit. Two more
(for a total of three) ofthe offices had started using water bottles and one
additional office had started documenting the refrigerator temperature on a
weekly basis. The documentation sheet was observed and the temperature had
remained between the 2" C ~ S"C range. These results are summarized in Table
4.9.
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Table 4.9 Summary of Results of Pbase IT. Post lnterventioa
Guideline found to Number
be deficient meeting
guideJinein
Plwel
n=27
Number
initiating
guideline post
intervention
0-27
Total number meeting
guidelines at the end of
Phase IT
0=27
Thermometer
Temperature
documented
Water Bottles
10
O'
18
Note· 4 offices had begun to document on a weekly basis but no offices documented
twice a day
4.5 Summary
In summary, the results indicate that physicians on the Avalon Peninsula ace
meeting many of the guidelines that ace applicable to physician practices. The
modifications that were most frequently recommended at the end of the first visit
included obtaining a thermometer, using water bottles, and monitoring refrigerator
temperatures. The intervention, providing information on proper storage and handling
including ways to implement those measures that were lacking, was well received by
those responsible for vaccine care. The second unannounced visit indicated little change
in the practice. The second visit also verified the findings of the initial visit, in that the
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methods in place were ongoing and not merely there for the purpose of the visit.
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CHAPTER 5
DISCUSSION
This discussion of the results will indicate the relationship oCtile results to the
objectives ofthe research and the hypothesis. The results will be compared to similar
studies from the literature that has assessed vaccine storage and handling in the United
States. the United Kingdom and other provinces in Canada. The results are also
compared with a review of the national guidelines to indicate how comparable the actual
practice is to the national guidelines. A summary ofthe limitations Oflhis study is also
included.
The hypothesis that physicians' practices do not meet the national guidelines for
storage and handling of vaccines was not supponed by the findings of this study.
Physicians' offices did meet the majority of the guidelines as evidenced by the results.
Recommendations for change resulting from an identification of the deficiencies will be
expanded upon in the discussion.
The hypothesis that an intervention would improve practice was supported as
evidenced by the improvement observed at the second visit.
5.1 Participation Rates
Historically, physician participation in surveys is low (Studnicki et 81., 1993;
Goethe et at., 1997). In an October 1998 survey request to physicians in Newfoundland
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and Labrador for response to a memorandum ofunderstanding regarding fee-for-service
and salary levels, a 55% response was considered excellent with the nonnal response rate
between 30-35% (1.. Collins, personal communication, March, 1998). The participation
rate is comparable to other cold chain studies in the United Kingdom (Bishai et a1., 1992;
Thakker & Woods, 1992; Briggs & lliett, 1993). With 92% ofrural practices (12113)
and 62% (15/24) of the urban practices participating, the participation rate of73% is
very good compared to the other studies, but there is an element of personal contact
which has influenced the participation.
In the urban setting, physicians had a participation rate of64% (38159) lower
than the 97"/0 (29130) of rural physicians (see Table 4.2). Several local events at the time
of the study may have impacted on the participation from both urban and rural areas.
Easter school break feU during this period and physicians' offices are typically busier
during holidays. Several offices had staff on annual leave. There was an outbreak of
salmonellosis in school age children in early April 1998, which may have increased
physician workload, and there were higher than normal rates of parvovirus reported on
the Avalon Peninsula during April and May. All of these factors may have affected the
participation rate. Salary negotiarions between the Department of Health and Community
Services and the Newfoundland and Labrador Medical Association had also reached a
difficult period (Gushue, J., April, 1998). No studies, which compared participation rate
differences between rural and urban physician practices, were found.
Participation rates did not vary by practice type, the same percentage of refusals
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came from both settings. In runll practice there were eight solo and six. group pru:tices
available; one solo (8%) practice refused a visit. In the less populated areas ofrural
Newfoundland, there tends to be more solo than group practices (L. Collins. personal
communication, March, 1998). The more populated areas ofSt. John's and environs
had only five solos and 19 group practices available; refusals came from two ofthe five
solo practices (40%) and seven oftile 19 (37%) group practices.
Ifan office was uncertain about participation when first contacted. as many as
eight to ten telephone calls were made over the three month period of April. May and
June, 1998. These offices were contacted again in September and October through an
average ofthree to four telephone calls and again a request to visit was denied. While
full panicipation was preferable, after- II·IS request!. funher contact was not made.
The research protocol had limited the number of attempted telephone calls to IS.
One ofthe concerns prior to the study was that physicians would feel threatened
and therefore choose not to participate. It is impoSSIble to state whether or not the
offices that refused did so as a result offeding threalened. When the visits were
completed, there were some comments from staff and physicians indicated that the visits
werewdcome:
..It is great to have someone come to the office and check: on what we
are doing with vaccines".
"Childhood immunization has always been a very positive aspect of
my practice and lends to the true meaning offamily practice, seeing
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people when they are well",
S.2 Characteristics of the Sample
From the demographic infonnation available (telephone listing for the number in
a practice and the Newfoundland Medical Board for number ofyears in practice) the
characteristics of the groups in urban areas who refused did not significantly differ from
those who participated. They were all in practice for over one year, had practices
throughout the same geographical area and the practices were a mixture of male and
female physicians.
In all 27 visits the person chosen from the group practice to respond to the
survey was the individual responsible for inununization. lfthe office manager responded
he/she did so on behalfof the physician who was designated to be responsible for vaccine
storage and handling, This method ofresponse provided demographic infonnation for a
physician in all 27 offices. Twelve female and 15 male physicians completed the survey,
The sex ofthe physician, geographic location of the office and the numbet" of years in
practice were similar for all panicipants, close to halffemale (45%) or male (55%).
Refusals came from two solo practices in each of rural and St. lohn's. both ofthese were
male physicians. Ofthe seven refusals from urban group practices three were males only
and three were females only and one group was mixed male and female. While this is
interesting, the small sample size does not allow for analysis of a statistical relationship
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between urban and rural offices.
Most (78%) of the physicians who participated had been in practice fOT ten or
more years. No physicians interviewed had less than one year of experience. The storage
and handling practice ofvaeeines was not related to years of physician experience.
On average the physicians give one to four childhood immunizations a week.
This was lower than the number provided by public health nurses who provided five to
nine every week (O'Keefe, 1997). One rural physician stated that he provides fewer
childhood immunizations in the late 1990s, but may have a patient who cannot attend the
pubtic health clinic because they are not offered in the evenings.
It is worthwhile to note that all (9) ofthe solo practices, from urban and rural
areas, provide less than one to four vaccines in a week (two or five a month). The
doctors in the solo practices explained that the ages oftheiT patients do not warrant
childhood immunizations. The group practices performed more immunizations per
physician, on average five to 20 a week.
The survey and visit provided information from 73% ofall physicians who
provide childhood immunizations on the Avalon Peninsula ofNewfoundland and
Labrador. Fewer refusals came from the rural area; solo practices tended to give fewer
immunizations a week and no association was noted between immunization practice and
the number of years in practice. As these physicians continue to provide childhood
immunizations the primary research question becomes more relevant: are the vaccines
stored properly and do they provide as effective a product as possible?
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S.J Guiddine Assessment
Twenty-four oflhe 35 storage and handling guidelines were evaluated in this
study. The recommendations. which are appropriate in a physician's office, were
assessed and data collected on how closely the guidelines were followed. This study did
not assess those recommendations dealing with policy and vaccine programs, which are
the responsibility of the province.
Solo practices (8) consistently met only 18 and 19 ofthe 24 guidelines observed.
Although one solo office that provided about five vaccines a week met 21124 ofthe
guidelines, the remaining seven provided less than four vaccines a week and met less
than 20124 ofthe guidelines. Group practices (19) met 21 ofthe 24 guidelines or greater,
but only one practice met all 24 guidelines.
5.3·1 Knowledge and Responsibiljty
According to the guidelines, 93% ofpractices had one person responsible for the
care ofvaccines. In 78% ofthe practices the person who was responsible for vaccine
care also knew the correct storage temperature. In each practice, the person assigned to
vaccine care varied, with office managers carrying the responsibility in most (890;') cases
and the other II% were the physicians themselves. The lack of an individual assigned
with this responsibility was a significant problem in the United Kingdom (Thakker &
Woods., 1992; Hunter, 1989). Having only one person responsible for vaccine care
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provided consistency and follow-up. This person would typica.lly place the orders. check.
the stock for expired vaccine. check for adequate space between the boxes to allow
airflow and maintain the thennometer and document temperature. Vaccine orders were
filled on a monthly basis. thereby eliminating the need to stockpile vaccines. The same
person was responsible in Phase n. with one exception, wh.en a maternity replacement
was also the office manager. The two offices without someone responsible for vaccine
care were groups from the urban setting. Of the six who did not know the correct
temperature two were solo. one each from rural and urban, and the remaining four were
group practices in SL John·s. The non-physician office managers who responded did not
differ from the physicians.
The person from each of the panicipating practices responsible for vaccines
responded accurately to many of the questions regarding the care ofvaccines. When
asked the correct storage temperature. some physicians quickly stated "refrigerated".
When asked 10 choose from three options. 78% gave a correct response. To the choices
of i) 50 _100 C ii) 00 - 30 C iii) 2 0_ SoC. iii is the correct response. In convenation, the
individuals who are responsible for vaccine care replied lhat they had received
infonnation regarding vaccine care from varied sources including peer review.
newsletters and letters from the Health and Community Services offices.
When asked if the office held educational materials on vaccine care all 27
responded yes. but the invesligator did not observe these materials. With regard to the
Canadian Immunization Guide. three (11%) ofthe offices were using the older 1991
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edition. The physicians with the old copies saw "no need" to purchase a new edition.
Eight (300/0) offices indicated that they did not have a guide and five (19'%) others had
an "old copy somewhere" but did not see a need to buy the Canadian Immunization
Guide. The remaining 14 (52%) offices did not know if they had a copy of the guide.
In late 1998 the new edition ofthe Canadian Immunization Guide (5111 cd,) was made
available to all physicians in Canada. In Phase IT all offices had the current copy and the
publication was also available online. This edition provides a complete section on
storage and handling ofvaccines. While all offices had a copy, no major changes in
practice had occurred. The simple provision of the guide did not achieve a behavioral
change. This had been reflected in the literature (Afifet ai., 1998).
Sixty-three percent (17/27) of those interviewed were not familiar with the
specific Vaccine Associated Adverse Event form (see Appendix O. The other ten offices
had heard ofthe form but had no need to use it. Discussion that flowed from this
question demonstrated that very few (less than one or two a year) had any "adverse
events" to report. Mild (expected fever, sore arm or thigh) adverse event reports were
not sought but would arise prior to the next immunization. No offices reported an active
surveillance for adverse events. Physicians commented that there were "even fewer"
events since the introduction of the aceUular pertussis vaccine in 1997. Those physicians
who had occasion to report an adverse event did so with a telephone call to the local
Health and Community Services office.
Of the available 27 participating offices only four (I 5%) had a concern about the
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present process ofvaccine distnDution. The same complaint came from all oftbese four
offices - two rural and two urban. This concern involved the method of documenting,
recording and forwarding this infonnation to the Health and Community Services office.
According to one of the physician's interviewed this task was "too cumbersome. time
consuming and required copies sent after each immunization". He conunented that this
inefficient method should be changed.
5.3-2 Storage ofyaccines
All offices (27/27) were equipped with refrigerators and stored vaccines on the
center shelves ofthe main section ofthe refrigerator. This was not the expected
outcome as the literature had overwhelmingly found that vaccine was not stored in a
refrigerator and ifa refrigerator was used often vaccine was placed in the door (Daniels
et aI.; 1991, Haworth et aI., L993; Steinrnetzet aI., 1983). Most commonly (81%) half
size or "bar" refrigerators were used.
With regard to the guideline recommending storage of"vaccine only" in the
refiigerator, the majority (96%) of practices did store only vaccines in the refrigerator.
In Phase I, it was observed that one of the refrigerators was used to store blood samples
and in Phase n, ofthe offices observed three stored blood in the vaccine refiigerator. It
was confirmed that this was common practice. Those practices. which stored blood
samples in the refiigeratordesignated for vaccines. were all in the urban area (one solo
and twO group practices). The office did not recognize that this was a problem. In one
practice, the fuU-size refrigerator was shared with dentists who stored their lunches
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there. The office manager stated that this could not be avoided.
It is recommended that water bottles be used to maintain the t~peratureofthe
refrigerator interior in the event ofa power loss. None ofthe practices under study were
aware of this recommendation. The data coUeaed in Phase I indicated tIlat only one
(1/27) practice (a group rura! practice) used water bottles; while Phase (] showed a total
ofthree (3/27) with water bottles correctly placed in two rural group and one urban solo
practice. This, linked with the lack of power failure procedures -only ome office had
such a procedure posted - could lead to excessive wastage in the event Qlof a power
failure. The other practices "did not see any need" (4127) or "knew what to do" (10/27)
in the event of an extended power outage. the remaining ten had no com.nent. The
participants also noted that they kept very little stock on hand; this helped to avoid
wastage.
Vaccine was transported in a thenna! carrier bag or cooler in four of the 27
(15%) offices. In rural areas where a courier is used and travel distances are longer,
thermal bags or coolers were used. In aU other cases (85%). the vaccine was picked up
by a secretary. courier or physician and transported to the clinic refrigerator in to to 15
minutes. The Health and Community Services offices provide the vaccine in a paper bag.
There are no studies available regarding the insulation value of a paper b::ag and the
guidelines clearly state that a thermal carrier should be used. These findings were similar
to United Kingdom studies that did not quantifY the results but reported t:he problem of
lack ofrefiigeration during transport as a problem (Briggs & DIetl. 1993; Cheriyan,
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1993; Haworth et a1., 1993). In an Ontario study less than 22% of physicians reported
the use ofinsulated containers for transport (Daniels & Naus, 1994). In Newfoundland
no change was observed in the use of insulated carriers during the second visit of Phase
D.
All 27 physicians' offices had 18 or more of the 24 guidelines for storage and
handling practices in place. This was contrary to many of the studies that had been
discussed in the literature from the early 1990s. Of specific note is a more recent study
from Finn & Crook (1999) which showed significant improvement over those conducted
by Hunter (1989), Haworth et a1. (1993) and Thakker and Woods (1992). Physicians in
the Finn & Crook study, much like those in this study, had started to use refrigerators for
storage and physicians have shown gradual improvement toward maintaining the cold
chain.
5.3·3 Temperature and Documentation
The use ofthennometers in the vaccine refrigerators was higher than expected
and was the most significant ofthe changes in methods from Phase I to Phase ll. The
literature review had indicated that few, ifany, offices had thermometers (Daniels et aI.,
1991; Hunter, 1989; Thakker& Woods, 1992). In Phase I, iO of the 27 offices (37"/0)
had thermometers, and an additional eight had purchased and were using thermometers
in Phase ll. These offices with thermometers had found it difficult to find a thermometer
in the early to mid-l990s and often the expense was considerable, ranging from $30 to
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S ISO. The offices with thennometers in Phase I included one (116) solo rural practice.
four (4/6) group rural practices and five (5113) group urban practices for a total of 10 of
the available 27 (37%) offices with thennometers. Those who purchased thermometers
after Phase I had done so as a result ofthe study.
In the rural setting two solo practices had obtained a thermometer by the second
visit, which made a total of three (3/6) solo rural with thermometers and three without
thermometers. The three rural group practices who did not have a thennometer in Phase
I had acquired one by Phase II. In the urban area, one solo (112) and two (2113) group
practices purchased thermometers, making a total of seven (7/13) group practices with
thermometers. Further, the offices that purchased thennometers post-intervention found
them more accessible in 1998 and at considerably lower cost of$20 to $50.
The temperature of the storage area was correct in 90"10 of the offices. Only one
of the offices (rural group) documented the temperature on a regular basis (weekly or
biweekly). Much discussion between the investigator and the person interviewed ensued
on this topic. Most physicians (25/27) regarded the twice-daily documentation of
refiigerator temperature as onerous. Two ofthe practices (one each urban and rural
group) had implemented a daily record when the thermometers were first purchased.
After a month or so it was found that the temperature remained constant; the practices
felt that there was no longer any need to record this every day. Others (20127) said they
observed the temperature daily, but did not document it. This was also the experience in
the United Kingdom, Canada and Australia (Hunter, 1989; Daniels & Naus, 1994; FiM
13
&:: Crook, 1999). Hunter indicated that only three of36(8%) offices had thermometers
in the reftigen.tor, this study did not enquire about documentation. In the study done by
Fmn and Crook, 27 ofthe 75 (36%) offices reported having a thermometer; 55% of
these read the thermometer once a day and one-third recorded the tempera.ture. Daniels
and Naus (1994) reponed that less than 15% ofsurvc:yed physicians used thermometers.
In this study, the one practice where the temperature was documented twice a
week, the physician explained that an event a few years previously had prompted the
change from non-eompliance ofthe guidelines to compliance. In discussing this personal
experience the physician related how the refrigerator had failed over a weekend and
hundreds of dollars of vaccine had been wasted because the temperature was not known.
This same office had a procedure posted that reconunended specific action in the case of
a power failure. Documenting the temperature had also ban a recommendation ofpeer-
review and once physicians or the secretaries had started to do so it was "just part of the
routine". 1be importance ofdocumenting the refrigerator temperature was discussed
during the tim visit ofthis study, but only one additional office (rual) had begun to
document tempenture when the office was visited for Phase IT. Physicians and office
managers who responded to the questionnaire stated that dOQJmenting the refiigen.tor
temperature twice a day seemed to be a waste oftime. One practice had started
dOQJmenting the refrigerator tempen.ture daily but the temperature was the same every
day for a month; so then they gave up the practice.
All offices (27127) documented immunization on the client's chart and aU but one
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(Z6127) provided the client with a recon:l of IUsiher immunization. One wban solo
practice physician did not provide a record; he gave the records to the Health and
Conununity Services office and it was up to them to provide the recon:l to the patienL
When the importance of providing a recon:lto the parent was discussed. the physician
stated that he would take this into consideration. No change was noted in this practice
in Phase IT.
5.4 Availability of Freeurs
The availability offreezers was not a practice guideline but was added as a matter
of interest. Discussion at the 1996 National Inununiz:ation Conference, held in Toronto,
included a new varicella vaccine which had to be maintained at _150 C. The introduction
of this vaccine would partially depend upon the availability of freezers. Freezers were
only available in three of the 27 (I 1%) offices surveyed. In two additional p~ices a
full·size refrigerator was wed but the freezers had been removed because they were not
needed. All childhood vaccines in the 1999 schedule are best maintained at 2".-80 C;
therefore the refrigerator is acceptable without a freezer. A lack offreezers in physicians'
offices could have implicatioM for the distribution of the variceUa vaccine ait was
reconunended as a universal childhood vaccine. Other studies did not reference
collecting this type of infonnation.
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5.5 Impact or Peer Review
While peer review was not an initial part ofthis study, it became it recurring
reason for the impetus to obtaining a thermometec A review ofthe literature bad
indicated that peer review is one method that promotes physician compliance (Grol et al.,
1988). From conversations with the physicians in this study. it was found that five ofthe
ten offices currently with thermometers (3 rural and 2 urban, all group practices) had
purchased them as a result ofpeer review. Peer review had been perceived as a positive
experience and the physicians who had participated stated that it was "valuable". This
had been the expected outcome ofthe peer review process (Cohen, 1991). In the
Newfoundland and Labrador Medical Assoc;alion Communique (spring 1999), the
proper storage and handling of vaccine remains listed as a "deficiency which directly
affects patient care" (p. Il). FCC" this reason the assessment of vaccine storage and
handling will continue to remain part ofthe peer review. The second unannounced visit
that indicated very little change suggested that peer review is more effective in
facilitating change than the type ofintervention (written materials) used in this study.
S.6 LimitatioJls or the Study
Throughout the period ofthis study, certain limitations may have been of
concern. The most significant limitation is that a bias may have occurred as a result of
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those who chose not to participate (27%). Those refusing to participate may not have
met any of the sto~e and handling recommendations. The non-participants, ten offices
in total. comprised 27% ofthe total available sample of37 offices. The refusals did not
differ by age, sex or geography of the participants; therefore, their practice could have
been similar. There is no indication that those physicians who refused had participated in
peer review. The letters ofintroduetion, sent from the Medical Officers of Health prior
to the initial telephone contact, had stated the focus ofthe visit. Offices. who may not
have been maintaining proper storage and handling orvacanes. may have refused a visit
for that reason, not the one given at the time ofthe request.
An additional limitation, which. may bias the study, relates to the letter of
introduction sent by the Medical Officers ofHealth. This lener, a requirement of the
Human Investigations Committee, informed the offices ofthe proposed visit as weU as
the: topic of study. It is not known ifthis was reflected in the h.igh adherence to
guidelines in those offices that participated. The fact that two different letters were sent
by the Medical Officen ofHealth may be a limitation, they could have had differing
impacts on participation. lfthe same letter had been sent the urban participation rate
may have been higher.
The instrument used to assess and measure the practice in physicians' offices h.ad
been previously tested for validity by peer review in the pilot. The questionnaire used in
th.e pilot study was refined to more accurately reflect the true situation in the office. The
questionnaire was comparable to that used in th.e Ontario Ministry cold chain assessment
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(see appendix D) which had been validated through peer review. Alack ofsimil.ar
studies prevented an opportunity to provide an adequate instrument, which had
established validity and reliability. The second unaMOUnced visit also validated the
findings ofthe initial visit when the same practice was observed.
1be limited time for each visit (15.30 minutes) could only provide a snapshot of
the practice. While storage of the vaccines was obSCfVcd at th.u time., it cannot be
ascertained whether the vaccine was left out during the practice day. Three oftile
offices had reminders posted on the refrigerator: "00 NOT LEAVE VACCINE OUT
OF FRIDGE". The interviewees denied that this had been a problem.
This study looked at childhood immunization as a separate entity from those
universal immunization programs that include influenza and pneumococcal vaccines for
the older person and those at high risk of complications. These programs are provided
almost exclusively by physicians. particularly in the faU of the year. Proper storage and
handling practices are necessary to maintain the cold chain for these vaccines. The
examination ofthese vaccines was not an objective oCthe stUdy.
Fanally, the sample size was a limitation. While aU physicians who provide
childhood immunizations were included, the small numbcn of participants have
implications for developing statistical inference. This is one ofthe main reasons that the
findings of this study can not be generaliz.ed to all of the physicians' offices in
Newfoundland and Labrador. While worthwhile infonnation has resulted from this
study, the large number of refusals in the urban setting makes it impossible to genenilize.
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CHAPTER 6
CONCLUSIONS AND RECOMMENDATIONS
The purpose ofthis study was to assess storage and handling practices of
vaccines in physicians' offices. It has provided a baseline for storage and handling
practices for those offices visited, compared them to the national guidelines, and
suggested areas where improvement is requiTed. The research has provided an overview
of storage and handling practices in Newfoundland, which had not been previously
available. Approaches to physician compliance were also recognized as a valuable and
necessary pan of any guidelines or recommendations. This final chapter provides a
summary afthe conclusions, recommendations and suggestions for further research.
6.1 Conclusions and Recommendations
The assessed practices met many of the guidelines, with aU offices meeting a[
least 18 ofthe 24 national guidelines. Those guidelines which were most commonly
deficient included the absence of a thennometer, documentation or the refrigerator
temperature, proper procedure in the event of a power failure, and the use of water
bottles as a temperature stabilizer. The intervention during the first visit infonned the
person responsible for vaccines of proper procedures and identified the deficiencies that
existed in their office. The largest change in post-intervention practice was the addition
of a thennometer in eight ofthe seventeen (4701a) offices. which lacked thermometers on
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the initial visit.
Noncompliance with guidelines in physicians' offices as an issue is documented in
the literature and reinforced by anecdotal information. For those offices that adhered to
the guidelines, the most cornmon factor ensuring compliance was peer review.
Continued support for peer review is warranted since it encourages compliance.
The recommendations, which may best address the shortfalls, would involve an
ongoing education program which would provide support for immunization and for
those physicians who participate. This may be achieved through the foUowing
recommendations:
The peer review process should continue to assess the cold chain and provide
support and background information for proper storage. A partnering ofthe Atlantic
Peer review, Ihe Newfoundland and Labrador Medical Association and the Health
and Community Services provincial and regional offices could facilitate this.
The Health and Community Services offices must continue to provide information on
immunization, storage, handling and documentation, and new vaccines.
The process of transport (using paper bags) from the Health and Community
Services offices to the physicians' offices poses an obvious opportunity for a break in
the cold chain and should be changed. This method of transporting vaccines could
easily go undetected and impotent vaccines could be providing an opportunity for
disease in susceptible children. Strict application ofthe policy requiring physicians or
Health and Community Services to supply thermal bags for vaccine pick up is
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recommended.
The use of temperature monitors should be considered for vaccine transponation,
specifically for areas where vaccine may be en route for an extended period oftime
(greater than 15 minutes). Thennometers could be provided (at cost) to physician's
offices.
The documentation of immunizations required by Health and Community offices
provides the required information for the proper charting ofthe immunization
experience. The fonn had been described as "cumbersome" and "not user friendly".
The development ofan updated, more user.friendly fonn or computerised
immunization registry would benefit the consumer, the physician's office and the
Health and Community Services office. While this does not apply to storage and
handling it was a finding when immunization was discussed with the panicipants.
Close tracking ofvaccine utilization could assist in maintaining effective inventory
control.
6.2 Further Research
Compared with other topics of health and of public interest, the storage of
vaccines garners very little publicity. Not aU provinces provide an audit process. which
would address the accountability of this portion of the physician's practice.
Guideline nine (see Appendix B), which requires twice daily recording of the
refrigerator temperature, was the one guideline frequently seen by health. care providers
8\
as "non-evidence-based". As a result, physicians questioned the appropriateness oflhis
guideline, saying it was ''too onerous", and contributed little to the maintenance of the
cold chain. The same response had come from the Health and Community Services
office when the pilot study had been completed in 1997; these offices now measure the
temperature twice a week. The feasibility ofreducing the frequency of the recording
should be investigated.
6.3 Summary
Most ofthe objectives ofthe research were completely attained. A good
participation rate (73%) for the completion ofquestionnaires and visits to physicians'
offices to observe vaccine storage practices. For all offices visited the intervention
materials were discussed and left. with the person interviewed. The second visit was
conducted allowing for a comparison of the initial practice with the post intervention
practice. The assessed practice was then compared with the national guidelines.
Providing effective immunization with potent vaccine will control disease in the
children and adults ofNewfoundland and Labrador. This is one aspect ofheaJth
promotion and disease prevention that has been engaged in widely for decades. While
immunization dates back for well over a century, the focus for disease prevention
remains on providing effective and safe vaccines. Maintaining the cold chain promotes
the use of polent and effective vaccines, which in tum supports the public health goal of
achieving health for all through communicable disease control.
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HISTORY OF VACCINE USAGE AND TESTING IN NEWFOUNDLAND
MEASLES' MUMPSJ RUBELLA
Vaccine I Code Name) Agelliven VH'startecl Y...rcll.n~
Measles- Live (Urugen) 9 months Feb '966 Sept 1970
Measles - (Urugen) 12monttls SePt 1970 O<t ,on
Rubella· (Meravall) 12 months Sept 1971 O<t ,on
Rubella- (Meravax)· GradeS Sept 1972 1981
MR 12 months O<t 1972 Dec 1974
MMR(MMR)" 12 months D~ 1974 Sept 1996
MMR 2nd-dose added 12&18 Sept 1996
months
'AIso offered to rubella negative women postpal1lJm.
DlPTHERIAI TETANUSJ POUO/ PERTUS!USI Hib
Vaccine (Code) "'.glven V.a, V••rCMnged
Ste.....
Dipthc:ria(plam) ll.ppTO>I:l940 approl(,!996
TelaJ:lus(plain) varied appro:<. 1940 appIOxl991
Pertussis (plain) <7yrs. ~194S OIlgoing
Polio, Sa1k-lPV varied approx:1955 m..,.
Polio,Sabin-OPV
.962 Augl978
-ReplacedSalkIPVfrom 1973 to August 1978
Diptheria Pertussis Tetanus & Polio (QUAD) 2,4,6.18mo4-6
",
Td&P OQgomg
DPT&P Adsorbed (DALE) 2.4.6.18mo4-6 May 1984 Seplembel" 1991
",
Hib conjugate PRP.D (CONHlB)
Hib conjugated PRP-D (Act-Hib) 2,4.6.J8mos J\lDC1992 Julyl994&afteTfor
1hoseootnx:civing
Pm.
DPT&PlHib{PENTAVALENl) 2,4,6,18mos July 1994 Scpt=ubel"1997
DT&PoIio (GLEN) 2,4,6,18mo lu1yl996
Focthoscnot='Civingpcnussis 4-6yn.
DaPT&P1Hlb (acellular pertussis PENTACEL) 2.4.6,18mos Sep<emb« .....,...
1997
DaPT&P CQUADRACEL) 4-6_ Sop""'b« oogoillg
1997
pJ2
T.bun&Iia Skia Tat: CUTVTlNEIM.u_OCC._
P.ODUcr T._ V.... sr.1'llMl
TubcreuliDskintal
.......- '948(Culitcsl)
-""""""
1951
BCOvaa:iDation
for lhosewba Wet'e skin lest
-~
-""""""
1951
TincTest spot cbedc$Chools. approxl972
emp1~e!C:.
ST.U.PPDMantoux IpproX 1982
2stq1PPD 1996
1975
ScptI975
1915
SepII915 (1979in
.....-)
Ipprox1982
oogoing
....... tu. 1975 ooaoiDI
Januaryl994 ooPJini
Januaryl991 oopg
All infmtsofHbsAgpositivemoms
oIferedHBVvaecioe
!iepa1lVU: first used IDd dwl&cd 10 Rooornbtvax in 1987
• Rca:mbivax IDd Enpix
•• Rcoombivax ooIy
AppendP: B
National Guidelines for Vaccine Storage and Handling
91
Canada Communicable
Disease Report
Oa. of puDlatlO/\: 15 June 1995 Vol 21-11
.....
• _.~~~~ .Iot.
....
.ce. ;" \~ReIeve des rna
transmlsslbles au C
..~.,-'
.~... -- <.../
o.teoepul::llicaDon:15
Contained In this i......:
NATIONAL GUiOEUNES FOR VACCINE STORAGE AND
TRANSPORTATION
Preamble
MaintallUllvaa::llICSatthcappropnazlulpenlllRfronllhc
ame!bey lean tM 1lWllI1al:lUm" (0 the umc cl ~lU$lnDlIft.l.e~
~of1tlCCl)Idetwn.II'YU)'llIIpOIQDtupec:lofpropc:r
~OdIYUYP'O@:tWI'lJ.l.ackollllillcR:Doellllhcc:aiddlllll..a
·".resv.kbodlmladcolvK:cuxdffQvmess..lIlIdrJevae:alll:;
bns.aadalllllCfaSednzeoflocal~Ii=...-m:
admiaiI..-. OIma.pCllbedanl:byUpoJIIllillDhcatorfra:zmg
ollben=mciepl:llom'lXllbellall;lR;ofchepfOduct.Rccal:studics
tlaftbi&bti&blld lIlajOfdcf.::1CftCa mc.aa.ur,wtdI rupea IOdleeold
dIaiIL 1bc0i1dbood1mmwlazaDoaDivme..BllIDUol
Comlmmil:able DISQK Epidenuoloty. Ubonay Cellll'll (or Di$eaK
CoaIroIhu.threlOfc,undoeruJwIlheul1IiaaYelDdcveiolllWlaW
IllIdelinesiOfv~ll\C.slOrageandn.nsponauon.lftcol1abcnuon
....illl lhosc penons bil~li III AppendU. l llle documents lillCd at thc
end oftlmappeno", wcre moused ltI fortt'lllUonlthesc Iwdchncs.
A workshopcm lIlr llflll:ll.C:JJ iliIpcr;g ol the cold cham W&$ pattofthc
:-lallOlloli ImmlllllUll.on COIUeunce 11lllIUIIIIDlI0001tlll:lll90'I:
Cba.lIoerlpsmdSoIuOOllChckl.ill~City.j·'OctcIbc:t.lfi4.
lbI:,.-tIC:lplllts&l1l\C.1O'Oriabop.ovo::r60iallJll:llliaDce. wU'r
CllC:GnpllIOCOllll'l'lentOlllDell.l1lOnUlIl*IiDcJ.
'ThiJ cb=De.lll IS pl'OY1de::l &S'lmaalcIIldcror~
1(lSalIDlllI.a1a1.lhe;\lltl~FO"'lden..lhemanuf~.ll:c
pnI"'VlQallllGlUnlOn.1lhea1l.b. ...._.uwdlubttldlllllWlaad
plIamlacIa. Bec:a\lKoilhc:Wldcaudlcnec.~mayrlDdll
lxkIntllllpeaf~rtcornmcncWlOl'lJiorlharpllUe\llarlllrudll:l1011.
SIldl~LCtnJ=lonsCllUldbedC\ldop::dIllIbeVVlOUJ
junsdICllOnJ.apeCI;ulvdepcllClln,onlhcniltlRofthcprodlK:tlllcd.
OpcraaonaJqllallC)n1 should bc relOlvcd by lhc:Jllnsdictiolu In
COllJUitalion Wlin tIlC manlllaclUrml). T1Ic: Childhood ImmWllz.loon
Di\lilion has tomml:lW mclf 10 1lrenithClUIli III ruppon 10 the
p"""mc::eI.IlId le."T\lOnCI w.th =pea 10 !he cold clwn anti will be
hlllllla~ollic:er;sspanoiIUK_pllllloo
vaccmc-pl'l:\It:l'IllOIC 1I11U~1 ac·lllf.lllu and daldrcn. lnJ'orma_
aboultealnlCai llllleS. ~n1I11.~cdlllCl--'srwenaI,dall:C to the
colddlamc:an~on;zanedb!'wno.n,lOl11C Chik1hoodirnlm.uuz.all.llIl
r)Ms1Oll. BIlft~ 01 CommunICable Ducue EOIdemrolol}'.
boraIorf'CCll:,"" :::r D•.u.c ConuoL TImllCY 1 Pulllft.Oua.......
....11_. KIAOL:. _: c~lllng 1-61)·937·I340or 1-300-Xll-b6S6.
Contenu du p~.entnumiro:u.- ... __
==:u~-=~~.~_=_~~.
~~.""",,EbolI.
UGNES DIRECTRICES NAllONALES POUR LA CONSERVATlC
TRANSPORT DES VACCINS
P"'ambul.
lA Il'WllllcndlCI VICQIlIllalCmpCn1llnl appropriCclpKllt6ll
.ibqllllJ£!llleslocallxclllfDicuu]IIIqU'.... IrlOIIlCIl'ouibJOlatc:
riI_c'at_WrcIe maI..IlUClldcbc:bWIcdlll'roid_COIlSll&UCIIIl;
prumniIII d'w propuomc de ...acclWIDII dficaor.. TlIUlC rupuft d
cia &oIdpanmniDcrllDCdialiDInIllIldcl'd!kx:lltclana::iLlIIlc
't8CCUIIJirdG ct\1ll.WAIIXnl d'cffclS ICCl:IDlIaIreLL'upoIIDoa lla
_plpcvvallcnclomma&u!aYat=l.l.~la~dapr1ldlail..l
riocrue. 001 mu cn~ 1lDccnalll.1lIOlIlbn= de pnlbIaDa ImJIOnZ
Caaadama:qw«ac:am IadlaiDcdll fn:Jid..LaDivisioadcl'ilIlIIll
dawlIlll:I.Burc:auder,fpidtmiolopcdcsmaladic:strlDlllliaibb.
Labon.~delullCCOIlaebma1ldicaOco:prisl'lnitiali.'ted'~
Iillludim::=naoonalaconc:cmalllbCOlllen'allOGCl.letrlllapOl
VICCiIU. cn COlbbonllOD avcc les pc:rsonnu donI Ie QOlII fi~ ll'a
NOIlI ROIlS 50lM1U elalcmcnt II\Iprel des doo.Imcnu cnlllJllires l b
eeue annue cn vue de II. Mdacuon du prismlCllilnes diret:lna:s.l
IW lei UPCO;U pruqucs de b dWllcdll froid. a ellt '=11 dans Ie cadl
eonfcrcnccnatlonalclllI"rilllZDllll.ll&llon.lI1l1l1lltc.:_L·I.lrllrllJlUlaUl
1lIDCelI'9O; delis ~lsolllllOl"lP.qlllal:llJIe"o.Qualce.dIl.5 at 700:
1994 LcsqucIqUCsa.unll:pcncnlCIqlllontp.ucipilClClIlClia"I
IDYJtts.rauedescollltrlCtlUllfCSl"'Ies~~MlIl:IIl&Ia.
~prismldocllmanseftll[lIDlIlIdc""paur_1OU'f'l
1·.nsK' lOW ICII proiCliliIOftDCls de bsanc. IW.I fabrXaots. _ at
JaIlIwrcsprovu'lCUkscllCl'1UCll'1l.ledelll&ncqll'aw;~des:
pharmacla.llcstdoncdallDll.IIlI ....,IItIWdUoin:Clc·atpl:U'qUlll
Icacun;dtplo«".llpeut~II'l:q1.l'iIIleOlllltlcmc:pudero:ontltalld.
sptafJqIlCS ,'appliq.,wtlto IeurSltuallon.Detd!CSllUUUCtlOllaapa
potn'IIelllt=elabolies"arlcsdivenm~selonlall&lllR.
Illliisot. CClIXoCl SCf1.lCnI nucWl l.mmcoerellcr tenIlItIClI quatiDlll
pratlqlJedecona:rtavec: lcsfabricanu.LaDIviaiondel'inurnmisalil
enJ'llIl1s·cSlcnlaaliellCt:I"Oiaesontpl)llilWlpl'tl'VincesetlW.llCI'I'
eeqwcorx:crnclaehalncdll!raidetcttlliauc:lx:nWl'lCllllCC:hn1:l\K
cadredcKlnpland'lCtlOIIpourlullCJ"OllIllRlesmaladiawtlOllm
Wcnf"IlSqlllpellVcnt&:e~parbvllCletlllllltla.Lcspenc
mll!reuccs peuvcnlscpnxura-dcl'iIIf~IlII"=--upca:
lUhmqucs.llcbf__&WlqucdlllllllllC!nd6ducail1enc=n:
I'MiraIC SUIVInlC: DlY1S_ de l"immualMlion des cnf~u. BIlI"l:lItI
I'CpIllcIlUOlol!lcllCIIltl&bcbcs IrmSIIlIssibles. Ubontotrelic lulU a
m&laCic. Pre TWUlCy. Oluwa\OnWlll) KIA 0l.201l m ICIqibana.a
1-61)-9S7·I)..l()oullll·800-361·6U6.
.+. Sanle:.maaa "
0".1'1I1 I'IICQmmendatlons
I, Pratuc=rdallD~tOlho=eolddlai.DJbouJdbernlewed
peno;lieaItyllaillevebli.c_e~oInOllUIIlDlyeart.
'Nhereuceun'eeolddwDflibDaOClCllf.r~ibouIcIbe
mcninquenL
2. Vta:IllCS Uposed 10 cempcnwra oa.tItde mo.lmud in the
rrau&cmrer I UlSCft Ill' IabcUiDlIIilouJd be:.1Cnld IZl a
~le.marbdCDl'lWDCrlllawcll-~...-ed
~unulc:al:llSlNCDDlllhaYeileal~vedOllwba
IDQgwnb~ Bec:aused:le~oldiffer=tvace:m=
¥In=~OIIlllClypeoilallpCnl1lReapcnte.~
~ll1UStoeC'+'UlaecillldiYldually.
3. RlCClnillbouIdbekqKoldalC:lrllCl:ln:d.lDCI.udmlklt
rmaDen fill' ex:lI na:ule I1:IipaKDLaad01-.&her
~QpsrJdu:shaftp..o.
----I. Vaa::lZIeSshould_befmlllftldflOllllbc~uceplfartbefollow1nl~:,"~adose(·):dliwlnIm
diata:or~lO__dirlia.Tbemnlemol'
Ib;Jrl!loulclllDtbeopeDfdlDOmquendy. (1'b&WOI'IdHea1lb
/JrpnIulloam:ornmenclliibaltbedoorlbouJdnotbeopened
morel!llllftlUl1lmeladay).
2. VII:t:llleI_bouldbemndintberefrilCBlOfulOOIIutheyare
recelYed.
J. ALI\Xl1ot1J~lpOnf.lblcfOl'bandtinlv.::alle'lhouIdtnow1he
QOI'fCCI_lORJetemperaturelfOl'tbevlrioulvlllXlllCl. *
4. Arefril_OI'deciieaudootylOvxane.aqe.bouIdbe
idlllUUJedlrrldlllCdontyfOl'tbispurposc. Vac:anereDilerata"l
dloWdllOlbelllCdlD.a::we~fl\llXbelIll'qllll:l-'
,. U1ben:IS III IIXIImUWioaol_lbaI em(1lI' 1J4 iDdll of
==f=-==~~O
boalll'bItIJa"refri&entorwllilt:tbililbc:ialtkJDe,.The
~lbcuIdbc:DlIDIIIKndliaoa&lhiICQl,U1'J&aII=Y
.....
6. o-~dlcluldbeidauiflllliutaplltllibkfarVKQlle~AlIlldletllld:i'ridaallbculd_bcnmaifOl' ~
wtlat me flna penon IS Ib:scDL
7A11vac:cme_lOl'aJCrUrip:rn:nItalId~.lQUUIllUD­
lllmlZllUlIIlIlt:l"mOmI:tUgr.1l1lrpquaDUtJelIoC~an:AOnIO.'CUlIlDDllUS~ra:ol'OlIlIOn'Ia..AU 0
InOllltOI'1llI~AloldcIbcc:crufICdOl'c:alibnta::l~iy.
I. AUrdnJWllllrlt:tmlllliqlqequatlQtiaoiYlCQlle(e..I~
oe:llnJvk:C:UledillribullDlltUSldloulclaaobclXllllXl:Zlitol
lalIpCnIlllteal..-mmotllllXlDll_ytlem.
9. TWocWIYlempenauerUlliiD.pfgrNYaCQllCrc&ipnuJr
IhouJdbetakenltJld n:ccnIed_OIlCln l!IeTlltll'1lllllwhcn
unVUllllldonellilleendddleaa,-1O_1,Ilelempen.llIn:l
renwnbcrwa:n2-CllIlirC.Adwt-recardin lthenrJ:lmeru
IhouJd also bec:hec:ked for lemperaturc~00lU. whicll may
OCQIr between readings. The dwJn&~ Iiiit' penon Ihould
reconl and_if1\ off readoua 101101 booicdaily. Thelksipwed
Itaffperson_bouIdelllllrcl!lar.a1lulffIwldliDIVaa:lnellknaw
how to Rad and lmerpn:t Il'IUllnum·mtrnmum thennomelU1.
o",c..L .Jt-K
Recommanciattorw g-.erat••
I. Lapnoq_rduiVCIlladlaillcdufroidde~elfel'eVVe:l
~t'lIOIaIielmveaux(c'est~ICIUIJa611lO11011
1es1llS).DallIlelcaauillamcideall(rupturedeladtaiQeduflOll;
_lrbllOlllbmIx.cetinterva1k~ttwplulecut.
1. Lavacalllqlli_tapuICIldes~~OII
RIpGievR:Ilc:dlelqai.mt.bldiqa6eIalrlalllClGcaoul'etilp:tet
f~~ttRc:amerrildaalUllCllllla&llldilliDa.
~~4EJIlD~£8ID1a.de=-dleel
Ia~CIt~JII8IPI'lc:&qae" c:laft
_l!a!~_Ies_lsuivft.t-dl:Dlf!;que
l'efficaattdedift'bmGva:xwl'.xscJD.ieI~
~ ib lGlIlapulCi.dlaqIIeUladem dl*twivaW
---3. 1I'f ....lJicade_desrqilDadel...~_.~de_poar~amJidevw:arll,..quedespc:nt
duel ... fatquc;Ja.dUr: de ptnmpooa est pas*.
~1'IIIatlvM.IaCClnMfYdon
I. U.faudntl,....raUa-anaD.~.wdptllll'
ra.- ••.,....;utiIiaaJoalfumoadep.....*-s;apidit
desc:.H:atsOll~am.diDiquesde'f'lClCiaaDlaDfalltouvnt
ponedurtfriPra-"kl:lD.lllXUYlllltpoaible..(L'Orpzusaaoa
___ dalaSaall!~de!lepuwnirlaporUlplulc:
quan fob pa jour).
2.L.avacanstlevnieofelfeplacbaun!~tlUlc:utn!c:cpQt
3. TouralclpctlonnelC;.:ison:t;::;::I=lm&llipulerdeav&eeUil
clevIcenlCClmlllilnlles~dclXltlXn'lllOtlrec:otnmlfll1,.
pourielcliven:v-=dnI.
4.l1faudnil:d6dia"w~llaeoaaet"<'llioadesvac:dllSc:r.
]'I1U1i1a UlUqUeSIleftt l =re fin. Ca n!fri&Uaenne~)t
'ft usiIiIb pour del alitnmll ou des Ip6cimaL
,. S'lIyaumlClCUrllll1lliodephlidelc:m(lJ4dapougel dc ltm
le~d·IlD~.i1fmcpma6lkr........... n
:=.~-====:=:=:==:'
--6. I1faadntildl:lipa"wrcspoasabledela.,n.... ....aos.lly
~1ieudcftlnzllll"um&ClCUlde~qaipounupra:
~cac:ud'abacDoe6urespamabk.
7. T_iel~l1AIU&ptIlII"la~da'llDl:lDl
~'Ife_d'lUl~l_et __DIL,
quaalll&llIlpOfQllladc...ans_--wa.d·U1Sdu:pos.l1i
d'Cllrc'-CQl,1lmIdela~T_"'applRlb«
...,.au.ecanr-,Ife.~OIIc:a1i.br&~
I. T_ica~CI:IlUellWde""q-atadevlDl:lSl1
ez&mple..a- a <:aiDa lkGis'rillDade. nccilD)de'mum1
qakmem'lferdiblun~de~_d'llndt.d·__.
9. I1faudraitpn=odRdaD.lcatlraquotitlimDtadatatealpCrarun=.
r6riatra-l'llDl:lDleteonsiperc:a~-_unclecu:
lII&linll'C'ririeetllDeaulfe.lla(lIIdetajoanll6t-wdevCl,
c:equelalealpUatureternaial:iemccnlfel"CetIOC,llfaudnu
'''mentvUirlUleanllClUltiotlllie~quipcuvcntll
protIuireenaetlemledurel.ll'aided'unUlt:naorio1ll
enrqu_ ppbiqlMl. L.a.penonnedtllp6edevnitnollll' Ie
lec:alrud'inltr\lllX:DlldallIunrqbue~jouretapptlllCl'U
_P1llte. EIlc devnit tp&ment veilb' l c:& que IOIlIa Ics penc
qui_tappcl6eslmanipu1a"desvaa:iluI&Clx:DtIiRUlldlermc
llllUllDlelllllllimaetm~a:l1cccuta.
10. Tow lei lIleIDbra dupenCllDel qui_appU6IlDlllllpllktde
vacallI~tret:C'tVU"uneformaoOllCCIIICCnUIUlaboana
lectllllqueslieCOQll:l"l'llDOIIerdctrmlpORdaVCCUll.
o~
Ccmral p!w'l:naae:s and. manufK= who rn:&U Ionl dislaDCe
UllPmenu shwld po::nodieally lISe cJcaronu; IDOIUIDIlI to deIcct
posslblc proolems and Ibcir locabOn.
Sl'IIppllllbo~fOl'IllOJIValrlllQ&bouldbcc:learlylabc1lcdu
CIlIlWlllIltperuilablesoo:btbalbavcl(lbcslORdbelWftll?C
iIIIIIrCaDdmlDlDlllbcfroz.cn•
.IAlIFlmsponCOlllpUUCSearr)'lllIv~shouldbeMinsed
lJlalllCprodualSpcnsbablea:ld:louJdbcrd~
'lIIlI:ICQWdyllllftlOelPl.o-recsblalldbcolllalDaithK
''aIXmeS are UplIJII rdnpnIedQl;lllWDer from~ ID
......,..
, Mamlfac::ll.lR:lJ l:boWl!*-n wnIICa~lIDIllIfrom
nDJpIII"IalIIlpmIa~dlebaDcillDtoipcnsbable
pnxb:::Is(~...m.acsbqeClDiilillllJ.1alph
ollillK~plCkupltlddejyuy.ec..).Refri&cnIed
wdllc:kssbauillbceqmpped'a'llb~1rICII:uIlIftIl
.......
6. lfIYlCOllesbip_llasbemn:fuJedbylbepastlllwno
0flXRd it the arnef musl kllow IIba Ibe shipment reqwes
rdri~pcndiDaraolu_oftbeproblem.Tbc
~uiKanrOl'pIlllIlolonllll muslbc.noIIficd~y
fOl'dlJplls;l1illllof~L
7 AIlvac:aneslhDlU:lbennsponediDanll1SlllucdCOllUllla'
wllha.llappropriU&nlllDbcroliecpldts(~whe:nabippcd
WKierrefriJCrUdllmlll). lnsular=1conl&lDCnsbou.ldbave
fil1Tlly-fittinllidslildbeCOllJ1l'llCledtromKlllllluWcd
mmna.!. TOlYOtdfn:c:LIIIl,vace:r.lICsl./\OlllalKllbeplaced
diteClIyon lIIeialP'Ck-
I Ai\j6OdyiiijlOililllklOl'IbeWplDallolvM:c:iDcmuJlcm\ll'll
IlIatllc'tKlCiaearnvesl.liupollllolcldivc:rylllhcpRlpC:l'_.
9. Bt:e:alJeIcc:plCbrmlO"CldflOlIllheli'r:e:zumaybeverycoid.
bd'OR theyarelllicdlhcy IhDIU:Ibcldtatroom R:I!IpCftllIRfor
I &:w IQmllIlel (I ." c\qlalIlil:l&lllIlhesizeoflbeieepKtmd
!be Illllial tanpcnan:lll:llal_ornrat~1llI1be
lUrfac:e101"!leama:Ibcnc:ciDes.
10. IfC'I'Im:-eofmezm, IS pr--...tlca qg;mcJ searil:ift 10
~areft:CZn'Cld(q..raalaol~
__),Ib&.-zuIelllll:SlllDlbevsed.
II. OnIpolionc:l:lll&sbcu.ldpnitr/lblyarm-e ....l1hsa:medl'yic:c
~pn::sem. lftlUYXaIlearmuwnboote:CremIII!IIiDcbill
.....mtbeproOuastllc:old.lIl1l&)'sliJ.lbeUKotilcrwe¥er.l!dle
"1ttltIC1S..m.lIsbou.ldllOlOCl;l$lld.
12.lnsublcdc:amttboaaJbDWdIlave~redabilily(_
bcnlidacdJIO_lbI:~~forlhe
mGCipaJcdIllLUlllllDllcn&lbof_reqwrcdfOl'lbI:
-~IJ. When vwxma semillYe 10 t'rcamI are III be shipped. iD outSIde
te.mpen;mres olleutlwl?C.lbq tboukibesluppediDl
vdlic:lemwhic:blbele~sllouklbeU9tb.lsbertl1a.ll
rC.lfthUullOIpouiblellldvacanelwlUbeuposedlD
OUtJIde!'reeDDIternpcnnftJ.onelbouldWiClCCplCltsWldl
wuullroornllenlplntlll'ewhc:npac:UnlthevilCClM.
AppoodIl
lJItOfCClilabonlton
.\1r.PeluCanuc:o. T~ealOmcufor thc ~antkd f'rosrmuDe
0ll1mlllunlU_.PAHO_ WHO. WulllnglOlL D.C.
6.Si\lQCll\'OidencallSatrdtlstp3l'k~1e
_qgcleprodaitdailtlRrmI.~~·lc:&qac
rqiLlldoiIlvuumlZlll!dialcrncntlefltlric:alltoal'Cl
_afilIquec::dtl:i<iluidoMc_iattnlClilllla~
7. TlMksv.ansdoiverl:!cnl~cImI.COII&l
rmfezmaallDlllOlllbrcappropntdelaptdl(AUfIof
c-. ~friIU'e). Lcs__alJoWl ddveatavoir 11II c
s~ el fIR fabriques d'un maWi.w bol.aa&. U IlC rau
Vll:Cllll~tSIl'JesIC~~.o:Itil."""",'lIic"
9.Pan::equ'Us_lrbtroidsllasonill.~.
OoiTaIIf.tre1aiualla~""'pc:mI.-
l ....d'f.nUisb(dc IlSmm.a.. p:at:t
~iUa.Je);usqo'lc:&qa'il ckl'e;
la.-fltlcafiDdeprna.IeJd.....::iIlJ..
IO.I..Inqa'ilyalicackmm:qgcac.-=cita-ab&at
c:apoIIblda~Irop"""pcac-.:k...
ClIaIIple.klnquela~In!~paIt:
a:sna::illll.lllldDiWlllpu&re'lllilbD.
II. Un_rmfrzmmtdcsdllw:Jdevaa::ill.orai_
"""'IIIlDtftCDllmlirde.laP-=-ddlelll_C
ledalltlltlln:..S·Ua',lplusdetlam:D*SqD&lI:'PI'C
Yat:IClDpeu:lqllmdlllCmcttreaDh2..hr~lIle·
....patueUl:lliJi..
11.::==Ia=:;::.ucaJ:~W:::
JClIlIIIuiI6c pmdaDt ... p&Iodc IIl&titDUe prm. pour IE
.........
I). Lonquc det ncc:itIS saaibles au addotwDtf.1R up.
hoid (EIZIptramres gme..a mf6if:ma l1-e),iLI
nupon&dmlWI'fibicIlIeckxltla~CJIfl
11Hcum; de 1 "'C. Slodall'Qtpat pmdble a qoe Ies
upt:JItsllD.~froidaulf:rieura.Ufautu
:m~ldel'CIII.Ia~ambiaDept.
AnnUt'
Uatt .. coIIaborat......
M. Peter Canuco. Ap:nl tedmiq\llC ptlIII' Ie Propwmnc t
~OrpIuPrica~dclas;:
W~D.c.
..
AppcodiJ: C
Questionnaire used in Newfoundland
.2
T7lis questionnQiu requestS informmion on ltnmuniUltion in your prtletice. The rt!SpOlUu
liTe cOfljidenliDi wilh no link berween II,e response slleello Ihe office.. TIre jinal rqJf1'" will
discl/sS physic:iDns as IJ group nOI individually.
9a. 'a the vaceina transponad In an
tlMrmaJ bag to YOut offtce?
Some «"litton. ,bpyr yp" 'nd ypur
IIa.<li=
Your.ex:
OFemale OV.. ONo
10. Where is vac:cine atlH'ed In your
_01
2.
,•.
How many years are you in practice:
0<1 01-9 0'0-19 020-29
1. your practice .010 or group?
05010 OGmup
'b. If no, in what type of
container:
3b. If group, how many phyak:ians
are in your prsctlce ?
Now 19m. qugtfpa. ,Milt lmm"alllUpn in
ODoototfrkige
O....in part of fridgeOther' _
11., Do you keep a thennornec.r In yaYI'
refrtge,.,tor1
.. Do you provide childhood
lmmunbtatlon. ? 11b.
DYes
If no, why not?
ON,
OVes ON,
5. Ify.., about how many
do you gtyelna~:
014 05-9 010-14 0;0.15
In your practice who is responsible
for ordering vacc::ine ?
110. If)'ft. don eomeone in,.
omc. record the~
DDaiIy OWeekJy
OMonthly ONol at all
o O=sionally
1.
8.
OP"¥sic:ian ONIne
asecnl:t.ry Othllr _
Who B respon.lble for checking for
expl~ vaccin..?
OPhyslCian 05ecretary
GNurse Othet _
Who picks up vaccine frnm the local
depot?
DPhYSlcian aSecretary ONurse
12.. How do you recotd Irnmvnb:ation:
(yoU may tick more thwl one resporISl
OWlittencnchart
OWritten on iii separate irnrmmizati1Dr
'""""o Entered on a computer recoru
Othe''- _
13. 00 you give a ..-cord of Immunbtati
to your patient (or parentI?
immunization Interview Number_
DYes DNa
1,". Do you regularly submit a r.cord of
Immunizations to the regional
community h.alth offlc.?
DYes DNa
14b. If yes. how often '1
14e. If no. why not '1
15.. Do you raport Vaccin. Atleoc:ieted
Adv..... Ev.nts'1
DYes DNa
15b. IfyH whet fonnet do you us. '1
15c. If ya. about how many in a ye.r '1
SgroI pu,mllS gn fmmqniDttpn in gin,,."
1'. 00 you h_. a copy of the CMad/an
ImmunJutton Guld. '1
20. Would you Ilk. more infonn.tlon on
the handling of v.eeln.. '1
DYes ONG
21. Would you like mora infonnatlon all
dtft'.rant vaccin.. ?
Dyes ONa
2Z. Would you like to rec.fve the raeult
of this survey?
DYes DNo
Would you eonHnt for me to measure the
offIee R.rrtgemor Temperatura
DConsent DRefused
If consent, temperatura:' _
Do you have .ny oth.reomm.nts:
DYes lJNo
17. What ia the optimum temperature for
vaCCine storage '1
05·10·C D2-8·C 00-3·C
Sgme fjn,l p"Uflpns gR'FF1!U rq YJsiinU'
18. Oae. the cu.....ntayst.m for
dlstrlbutlon of vaccln.. m..t your
needs?
DYes lJNo
19. If no, how could It Improve? _
Immunization Interview
Many tn.;nka for you time end
participation.
Number_
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VACCINE unuZAnoN IN ONTARIO
WHAT ARE YOUR PRAcnCES?
TlMi key .-.on in yow PfKtice who i5~ fe.y~ ec1ivida--..ad
comcM".-1ions 1 - 3Softtliliq~.~ 37-U.... be~ by"
.....-.
PIaase re1UITI to Stacy Dani.... Vacelne Utilization Re¥illw Pnliect Coordinator. DIM... Convol
Service. Public Heatth BnInch by Sept,mbllf' 10. 1992. A stamped••eIf addr..Ad envelope
has b..n provided for this purpose.
ThaM you for your~tiOn in this study.
1... _ _.ffi....tw __
=..~I _CM. _-..,."
11_.....",' _
LIo_.writtenjoob<l~loI'U-_
......~..,_.........1
11_...........,, _
S. ::'='i' how orton 01. yOU ............. ----
fO/loc<III'uDic:KNlU.C__~o...-G
leI .........
..-
1I_.pI_~_-----
•. o.._.ho_..-_.I_loIo""",,
_ol_<loyOUu...."I\montI\l
0 ....
0l"V :=::00.-
... --"-
---"-
" --"-
'O'~':'-;":;_''''''''''/'OII.............. .-romtIM_.,;"g
{.IOffI... Stafl'lek_ {b~Cou...<s."'G.(olG VTn>d<{dIOtIM.
I'. o..rw,.-.,uo_•.-. __........~o,
_·_.-...vtr~ __,_-.
-
..-Me.-.. , 5
lc."'-' , 5
::::":=tod COnui..... : ~
=:"'..... ~ :
0_. , 5
~f'y: -J'
1.... _.ofrieoot__•.........-..,.... .....--.__
........_,...._-,
._---~--_.
15... -. • ......,..,_ _0'
__....... otwNch _ 10...-..-'
1f_....... ....-v: __•C
1•. 10-.._'.. .....-...._,_
;,.,-~,
17. Do ...... ;" .... boDk ....~'
12..~ ._ ... _ .. _
-, --, "-.
..........~bl__ ffic.
"' ..... offico /•.I_1>o._p"""'.1
._... olV......
13. Wlwllo __• typo.......... of r.~._ ..Md,....
"............_in_.ffic.l
:.:;_ .... __. _howo_ .... _._
IUDoitv (blWoekIy
{e)MoftlhlV (cQD--= _
"_.....w_*'-, __
T,....,/O,l-.....,.
....-ld._IoIpocifyI: _
Slc.:/O,lNltIiH
.,....,•..
(GI_(~' I '-'-, "-.
10. eo ...... ·_Ift,.,..d_<OI1M_.
._.- -
. ..
1I__• .,.. • ..;a~ ......... '"'
_·_.... ·_... tMf1
1f_.pl_.....,;tywhic:h"..,.......J.'........
""""10_. .........
._.-
,
-
,
-.
-.
27. Do ......__~on _
-... ...........,
II _ • ..- ....lywt.ich ..-ciNwl .... _
...............
D. Ho.do_~of_·_'
W"-..__~
1bI ~"--Y
1eI_ .......
~W_.....
l"OU-~ _
30. _...--ef .. .....-.- .._Ift ...... _
_ cIloc..-or reN"" """""'_'
31. WNch _ 0' Ih<o folowing VKCI....... mo.,
c""'""""vdi.........:lor ••w ...... ,
CI_"-Icornmonl
"'"
"'"...
_ ....
_OChorf_tvI _
)1. ll........... 'oIo,..;ng._fof_1oP
fr""_GOfNnOf'lflltofe.MI __ "1
T__ chenoeedunng~
T__ ci'>IoIOHdurinQ.IOfeg>e
T__chenoeedurinQhendlinv
bpW..:ldMM
0Ch0r(1IIPeC'ifyI _
U.Whlllfac:tote .....linyou.p.ac:t>«theClnc'._the
IikMhood ..I \/1IOClinn boong dieoeteled1
37. Wha<.diclyou ...... _ebout...-w..toteoeend
-.-,
~ ......... Schoot ...~~
(c)Joumele ldJ~~
I.........., fIf HMtdI If) I"roduGt w--.
...,~ SMet.
laIOttMflepeoify!: _
38.lIyou"--...,qweIioow--. ....... (eg.
imTunu.............. itw:licaioN.etoJ• ...no.
___of'lM7
(al1)oqI.... 1n ....... "'..--
a»DoctoreIn~InAl..
Cclatt-tue-
~I"ubicHMfttl~
(eJOntMioG_""'-"-Y
(f)Ott>et(~: ~_
...........
I ~­.
4O.c...VOU ..limeutheo toteidollM ltheputliidy
runded ........... VOUl.- _theol..'
-,
..
41. Doyoulhlnlll'fMiolen'.~........ ___
etl'on I .. mlnimIu _._,_,
)5. WhIIIinfofmeDofI ............u ....... ......-..
.-dec! _ ... "--'. ",'-11
.....
.....
,.,.
tMme of V.......
-
ll...I.
sll.ofltlieclion
...-
u.r.rl...tu...
Slgnew••
OthefI"'''.I'''''';fvl
3$. Whetlnl Iion .... lnwovniulion ••oulinely
,eoorded thep.li.nl'.c lnwov.u dl
41. Do""","--""_Of~1Ibwt
howwm,_tlwnoreoeendhlndllng .., ........1n0nt.001w..-_bIolkfor__1
THAHf( VOU VERV MUCH FOR TAlUNQ THE T1MI. TO
coto\P't:OITlUQLIUT1IONIUURf.
""',
KtMl.. "-Vl.&EUUTHa~EHVIl.OfI'f:
PflOVl:)lD AHD ROURl'lIlI
0.1.
Neme ..IV_...
-
....
...-
....._-
.......
0Ch0r1nfo.~f¥l
Appeodia: E
Informed Consent
94
[nformed Consent for Participation in Immunization Practices in Physician
Offices on the Avalon Peninsula
My name is Carby O'Keefe and I am a graduate stUdent ofMcmorial University ofNcwfoundIand. M'
professional background has been in Public Health and Disease CollttOland Epidemiology. As part o·
my srndies I am conducting rc:seazch related to immunization practices. I have received approval &on
Memorial's Human Investigation Committee: to conduct this study. I have also taJ.ked witi
tqJreSentatives of the College of Family Physic:ia:ns., the Newfoundland Medical Boatd th
Newfoundland and. Labrador Medical Association, ColD.Dltmity Health St. John's Region aDl
Community Health Eastem who are aware ofthis study.
Pumgu nfStvdy-
To assess prae:nt immunization practices in physiciaos offices with panicular fC1CU:5 on storIg!:
bandling and documentation.
To provide information to support proper storage, haDdling and documentation in physicia
practicesettina:.
To l!SSes~ the change in the immunization process in physician practice setting from an initial t
a second visit.
To compare pre and post intervention practice with national guidelines.
Daedpdop ofPmCcdYrc:
Today's interview will take about 10-15 minutes and with your pcnnission will involve question:
measuring the temperature of your remgc:ra1Or, and providing infonnarion on storage, handlin& III
documentation. In three or fow-months I will drop back aDd discuss with you,. oryoursecmary, tile ~
ofdocumentarian materials and wbether or not they arc effective, measure the refriacrator tcmpc:m1W:
and collect any comments on immunization.
Confidentiality;
All ofthe information provided wiU be kept confideatia1. A code number will be placed on the intcrvic-
form and these will be secured in a locked cabinet. lhe idcmification ofphysician practices to the coc
will be held by my thesis supervisor Dr. Bill Bavington. Memorial University.
I labjUfy Sla'emmt;
Your signamre indicates your consent and thar: you have understood the information regarding tt
research stUdy. In no way does this waive your legal rights nor release me inve:stipmrs or involw
agencies fuJm their legal and professional responsibilities.
Thank you for yoar time and cooperatioa.
Consent for Interview loday, measurement of Refrigerator Temperature aod a .ecood visit:
three or four moaths:
Participanl's Signamre Wimess
Appendix F
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l1=R.9.1'39E1 1:28PM EF6T CQ'T1I-t..TH H='P m.718 P.2/S
~P,-...rA:k~
COMMUNITY HEALTH
£ A I T I: l" a. E a ION
Eastern Newfoundland Regional
Community Health
P.O, Box 70
Holyrood, NF
AOA2RO
Fu: 709·229-4005
C.£Q.'s omee_no.....
B""omceI
..........
709·%19-4124
--
_m.m>
PabUc Baltb Naniag
_eo..
--
RehabiJie:me-
7Ot.m-4I12
701-=1351
Health Promotiobl
Protection
""'"""'""*-
""""'"lmirolUMl:ltalHeallb.N__.........
CIdId .......
m·m·3J67
}fental Health &
AddictioJlS Senices
709_229·3353
Febnwy 24, 1998
S£
P.O. Box 299
Kd1igrows, NF
.. ,-QA2TO
DcuIn-.~
--'-'-lmImmization continues to be the principle method of primary prevention,
cspccWly m t1le~ ofchildhood iJlfccdous_. Phyo;cians play ..
importam role in immuni.r.ation in Newfoundland and Labrador.
Within the next t'\:liO months you may be contacted by Catherine O'Keefe, a
gndu&to =dent in ColllOlUcity Health, Memorial University ofNeMound1wl
who is conducting a stUdy on imanmization practices in phyJician offices in
Eutero NewfOUlldiand. The Newfoundland Medical Board. Newfouodland aod
Ubndor Medical Auocialioo eod the College ofFaoUly Phyo;cians are all familiar
with this ltudy. The objectives of the study incWde:
To assess immuniwion practices in physician office settings with a fOCUll
on storage. handling &ad documeawion in immuniza%ion praetices.
To provide information which supports practice guidelines cacsisteru with.
those ofthe National Advisory Committee on Imunmization.
To assess the change in pnctice from the initial visit to the second visit.
To compare pre and post inlervemion prac:tice with natioca.l guidelines,
"National Guidelines ofChildhood Immunization" National Advisory
Committee on lmmunization, December 1997.
P.~
A viait: to your of&e wiI1 be requesud which will tab appraICimately 10.1S IDimne:s of yOW' time.
n. infonaaiaa. will be compiled. in study raWIs.
IdxmItion aD iadividual practices will not be availIbIe ill the result.. whicb are expected to be
availabJe in Iue 1991.
We bope to c:owu. on your c:oope:ruioIl with tbiJ SOldy, wbic:h 1D&)' camn1atte to improved
iam:lImizaDoa pncUca &lid a beaItbier populadoa..
Ca&bcriDe DonovaD. MD., M.H.Sc._MatiOII_OlII=
COl'"
March ll, 1998
Dear Physician:
Re' V!cclpe Study
Within the next two months you may be contacted by Catherine O'Keefe, a
gr3d.wue student in the Master's Program. at Community Health. Memorial University of
Newfoundland.. Ms. O'Keefe is conducting a study of immunization praCtices among
physicians in our region. A smaJ.Jer stUdy of this nanJre was carried out upon physicians
in the SL John's area last year, and was well received. lbe Newfoundland Medical
Board, the NewfouDdtand and Labrador Medical Association and the College of Family
Physicians have aJl been consulted regarding this projocL
The main focus of this study will be to collect data on vaccine handling before
aDd after infonnation on the National Advisory Committee on Immunization guidelines
has been provided.. An office visit of between 10 and 15 minutes will requested.
Summary infonnation on the study results will be available to participants.
1 hope you will consider participation in Ms. O'Keefe's study. Sbould you have
any questions. please be in touch.
CI"W
ANN ROBERTS M.D.
Medical Officer ofHeahh
AssislaDt Executive Officer
..c.....-_
....lJ:.~ 1'0._.1 r.o. .... ;"" r.o._~ ..... =_M ~-~ r.o._n
"'r.o. .... UI:: !'O.Bo.o.III;: _eo-.NF w_~ ,-~ a..-.NF
=F
_.
,,"-=flF s..""",... "",
-- --
AI"I~ _.Q -~..,,,,.... ~ ~ 111·1071 ll+-lDI .U·19Xl'--14
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COMMUNICABLE DISEASE REPOIU
Province ofNewfoundlaud and Labrador
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VACCINE STORAGE, TRANSPORIATION AND WASTAGE
Ia thelune 1995 issue aCtbe Canadian CodllDUClicablc Disease Rcpon. Nanooal guidelines foc
VllCCine stOl3.gc and transporWioD.~ rrleased. MaintaiDiq vacciDe at the op:ima.I tempentUre
(%- to 8- C) from the time it leaves me manufacturer until administnrioD (maintaining the cold
chain) is a major issue {or those who provide immaDization proarams. Wbcn lbc cold chain is
imerrupted. there is a possibility of reduced vaa:iDc cffectiveoess.. vaccine failure. an increase in
local. reactions post immuniz.:l.lion. and increased vaccine wastage. In summary:
Keep refrigerated.
Refrigcnue as soon as it is ~ved from the shipper.
Do Nor store on the doorofthc refrigeruor or near the freezer section.
The refrigerator should not be used for anythinl else (ee. luac:hes).
Refri&CQ1Ordoors should be opened ooly IS often as necessu:y. aDd (cranl)'
as 10Dg as necessary.
The freezer compan:meDt should be kept ice free.
Ice packs should be slOled in the f:recz:cr section and water boatcs
should be SlOlM on the doors and lower area to slabiliz.c tempcr:mue.
Make sure door is closed when not in usc.
Space products to aUow (oc circulation of air.
ODe penon appointed for vaccine management sbould:
- Be trained regarding lite imponancc. of maintaining proper temperature.
• Do rwo u:mpe~ readings every work day and record same.
Other vaccine related concerns;
One person responsible to ha.ve a procedure in place to mainlain cold chain
in the event of power outage or rcfrigcralOr failure.
If vaccine is returned due 10 possible exposure to heal or freezing. refriger.J.te
in i1 box labelled DO NOT USE until exposure is checked and advice obtllined
regarding use.
A poster with infonnation on cold chain should be posted in:ill vaccine storage are:l....
Complete regular maintenance of equipment with recording of same.
Place a sign ne.ar the plug of the refrigeration unit and electrical outlet to ensure the unit doe
not become unpluged.
For those requiring specific information on uansponation of vaccine please refer to CCDR Vol. 21
11 p. 95 - 96.
Vaccine Wastage
The total vaccine wastage for Newfoundland and Labrador for the five year period 1990 - 1994 wa:
approximately four to six percent of the tota! dollars spent on vaccine annually. While this is a
significant amount it appears to be low compared to other provinces who have researched this area.
A vaccine wastage report was done for the Department of Health in 1995. Many of the recommend
tions of this report were similar to those found in the national recommendations for storage and tra:
ponation which have been discussed in the previous section. Some other recommendations have b
made specifically regarding vaccine wastage. they include:
Vaccine users should order and stock only the amount needed.
Retnm soon-to-be expired vaccine for redistribution in health uaiL
Provide infonnation for all personnel involved in vaccine handling and storage
(iacluding public health nurses. physicians. clerical and cleaning staff).
Place a poster on the storage unit with facts regarding vaccine storage.
Ensure the availability of adequate packing and storage materials. including: ice packs. insu
vaccine bags. styrofoam boxes. cold and hot monitors for en route packaging ( for long disc.
transport ).
Use couriers who have been infonned of the importance of maintaining the proper tempetar
The recommendations discussed here are also included in the Newfoundland and L.abrador
Immunization Manual p. 8.3·2.
Cost pet dose of commonly used vaccines ( 1996)
DPT&Act·HIB $18.10 Td & Polio $ 8.35
Influenza :5 1.77 Hepatitis B(l mJ) $17.35
MMR $ 8.21 Rabies vaccine $62.14
Rd'e"aces:
En.lu:nion of Yactine Wa.su.se. Disease Control and EpidemiololO'. Depanment of Health: April 1995.
Nalionai Guidelines for vaa:ine stor'll.se and U1lnsponation. CCDR 1995: Vol 21-11 : p 93·103.
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PREAMBLE
Tht .\fwo/wi (;""ftllnts for Chr/dhood Immumzallon Pracllcrs lun'f: httn dt~lofXdbl' 'lit .'all:mal.~dv/soryComlllltll!t(.
f",mrmr:allolr IX,ICll through (Jl'I t%ltnSI~consliitatlon proctu. nit,· art (Jr, Inttgral pari 0/achl~l1fgaur n(JlIOflol.ll.oafJ
rRdlntWIf tor ,'tJCCl1ft-prrvr1ffobft druwts oflnf(ZnU and chlldnn. n,t purpost ofthnt glfldtllnn IS 10 adrltvt a .Ifando
ofpracflcr II'Of ....,1I tMlln VGCl:'mts on handltd proptrly and dtllWrtd to all chlldn1f w ncommtrtdtd by provItlCiollRtd
ttrnlonal programs.
[_"':!IlIOn IS a IIIl1Jor co~ntont Iff o"r tffons fO ImprrT't't dw Maim offNOpk all Ol"trlht world. It -. rtJpomlblt fo.
dw,/oItoJuothcOUOtlof_ol/ptXLI1f /977 andw tl/lfl'tfDUOtf afpora/vtlc poIioIII.wlms Iff iht ..."tSltmItntup/wr"tas
cnnfltdh1·/ht P(Jl'l~Ht(l/mOrgamumonIff /994 I"ca:uJt-prtvt1fUlbltdutasts hawapt~otfftrtttdous
d«rtMt InC~ dtllfOtU_/1If dtt tfftctNt_u ofnu~PrT1VfncroJ and ttrnumoJ progrrau. e-i dw AlCUujill roI
pkIynJ h1' p,.,\!tJJt e.od f1/Jbbc pn:wtdtrs. C_partd to tlw pn~tIIttra. W Ct7lOliJan odutw"'~tJ '-b«rr rt/llflriob
owra 'JS"iJtcrrast DrwmadtlfCtoflllQrl\/dJJtaJtS _"'t/DItJ. ItMUtw ,ffjtctionsdflt 10H~~~
fiftdlhtctJlllpktttl..._afpollfJ.
o.Jbrr__1 o(\"(~cr:mt..",-rw1fUJOIt dlJ~aJts ocr:,u. ht1'Wn'tr. as J"!Ir,,,lrt~bv ncrnf tptdtmreJ of"'ta$ks rad ptrtllJJIS. In
addrlll'" "IUS OICOffRmila/ nJlNllo n'"liromt conI/mit 10 or:r:ur ThtSt Ir~bun ",mbllltdI~iy IfJ madtqllllU
_mr:UZIOlI m crrtourpoptlolJO/U. Tht IncrtaJ~ In ptrtJlJJIJ costS '" C~~rrtcr1ff.Wlln.W IIIfporlDtJOtlOfWfIJ
polIO ,"'u U/ 1991 and 1996 IntO CanDda and 1M dlpiHittnOtpldtmU:l1f £aswm £UroptanCOllntnts rtwItttdlU rhoI tlw n
for /ht.t "1J~astSsrlff tzUU tksp"~CIIrTmt progranu. lind thOl th~ I"wl afprottCtlan oftht pof1/JfonOft ImUf Itt ktpr lI:J Iri!
mpoJJmlt.
Tht \"tI1II.. o(,nJmunllllJlon h03 bt~n dtflnll~1v tuabilshtd. Ollt ttnds to tokt IU bt~Jju for gran/td and lIS l"tl)' SIICcrss
Ite III cOlllf/factm:v. Il't no Iongtr su tlrt dtvDStolmJ tfftcU a/''OlXlnt-prrwntohlt dlJ~aJts..\(onowr. btCOUSt aftht
Iv-Jr..<JllrJlC....· ofOCCIIrrrtICts. tht opportnt bDltmCt ofrisks and bt~flts ~'"s to Jhlft IOwtmis a gnatt,. ptrr:tptton oftm
mb. ii,~ 1II"()rrunol~Impilcotion IS thOt mart ptopft mayohDndotI ar t~1f oppost ImmllmZOftOll. A ncrtIJ IfaIUNlol s,,'"')
rtWm...1111m Ih~ pllblle WaJ w~1I mformtd bv h~olth-cartprovuJus obolll tht nso ofsidt t/ftcU but /tSS infornttd llbo"t I
btnt'''' ",r;·cclnng''l2CClnts.
Somt .• , ",,' .'flClhllslltd nO/lOfloJ floals and lorg~lf;,lI\Itbun achlt\"td and"ooriPrD!rtJS IS btlflg modt ro-ds Iht ou'u'
butl/lllt". ·;i,,11S J/II/ nttdtd 10 nach tlrtm all.
!>tvtr-I' >t (.:In pamllO lilt tlttd/or SOl/OIIol G"wtltms far l'llIldhood Imm"mlllJlOfI PriX'lets.
""I'lllrm.nmtd tSnttlOltS afWJCC/1fotIOll CO\'f!roru fOr ]-I"tOT-01ch In ClIIIlIdo J/to'tII' anasjor concrm. Co,w~..
••" ",." dosts afpt""SSIJ. ftlDlIUS anti dlt/I"htno nIlCC'In~"'_JJ7" wnns a I~' af9JK /n rddJ/iM. IMrr If
~ t" III> c.'O'",rm,:t jor1f"O'ipJ ,hm af'pau vaccinal/on Qn rtr"l/OUS l!'roItnas. ana COI't"'!t IS ll~jor,1w /II""
Apni: ·...)8
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1I(/lux 10 ('anaUJ 0/Clbouf 60,()()() norcom~n ... /8.wtln 0/ag~.
Page 2
n~~ orr mlJJ~doppo'tunlt~Jjo, ~mtU,on1ft CanatilJ, rrSll/,urg In prtv<rn,oht~ mortm:Ju')l and IttoffDJity, tn 19
and 199./. '~JptCuwly. 17.J"md IJ.rmofl:aJ~Jw.tir HlltmopI._~~b m/taUNfOCOlT7'tdIn
duMrm who worn' tftg.bk 10 f'tctIW Io'lJa:t1Ir bu' did 1ttN· _ /U D f'tSllI' 0/pqrtrfra/ tkcuil),u ftIN 011I _IDIIU b
oIMn /lJ D ,..mlt o/moppropnau tk/t"'" ofurtmunlZDJ_ 0' jat"",.. to~ W WJCI:UIC' ltJ f'tt:OmlPrCldtd.
T1w COIIflJlll~d JII«nJ ojroutJtw r:IIlldMod ,mmll7l/Ul!lOn nt[II'n'J drat ttilthost urvo/wd. inc6Idinr poiicyllrattn. pn7gffI
atMmutrr1fC1n. and pravtden'aU 0 pro-«tNt "fJ11"1"'CIJ 10 duldhood DtUnrmmtlDrr, and wort oIIIpwr 10~ and
",Gllltam a i"gh Jltndoni ofuallmu In p/arn~, c:'Oftducll1lg, and 1"nWW"'! childhood inIJmInlmtll)fJ~
,\'ACl ~",bari~dOft a prtJ«JJ ojdtwlapllfg guKklmn fordliJdhood un-tuZlIQOI'I' practicn rid COfIId H oppiitd to
nlnTftf public DIJti pnvatt ryJ'tlflJ jorWCClnt dt/Ntry. 1M gllldtliMs _,... fint dTaft~dIn I99J. 1My _,... fTVU~do/ftr
l.warJ ofconsultation Wltir pt'fMl'/ClaJ and ItrnlOnai hto/th QfldtanlitJ: pro/~sslOlf{J/mttlicol. mmlng, plfblk-INoJih. anti
ItMPfltti oryranlUlt.oru: Individlltti pnMrkn: and child advocllCY group.; and dUt:u.uion OJ tht 1996 NOIioaIi I"'MWlWltlo
COflf~,..nct. rn~ haw b~~n mdon~dby 1M COIIaill11l Potdiatnc Socwty, Hettitir Canaio's AdviJoryCOMM,tut on
Epid~mloIOfl;l-·.t!r~Collegt o/Famllv PhyliclonJ ojCanoda. th~Canodil11l Mtdictti AJJociotion. lilt Canodi_ Nunn
,iuOCIO/lOn. rllt Aborlgmal Nu,s~sAUOClalton ojCanodo. and /ht Sacltty o/ObJl~mcIQluanti Gyn/NCOlogisu ojCanotk.
17w gtlttklmts an! chlitwrot~1ybNXld.j"NTad,,"K. and rfgo1'Olls. Dtfintd /IJ dincnng pnrrclpln, they f't(JfrJrm tht MOSI
chslrabk Immllnrzotion pfUCllct. /'N:rvrdtn CQflllse /htffl to alSeJJ thtlT~"""'"pnxtlcn, and to khnllfyarras ofuu/k,
as _II /U artQ;! ntpl'''''K ''''prow'''~nt.SoMe oftlw gulthlws nt{Uln the irrvolvvnent ojtlw prtM1IJCf!S rMdltm'on~J /~
rJwMN la,rad:illl..lUlWWoru rMdrJlldJ'Cl1W1"agI' tnT/d. FllrUw""OI"t, somtptTJ'llWJtnmd~IftOy""/rtJW tlw
IfIlf%JJan>.futtds to ,mplltnml tire ptdttlintJjidfyOl this uIM.lnmdt Ns~S.W guldtfintscarra:tCU"aollloilo twt#rtkjin
~=OIInuds.altdlorlt_m:rI~tht~tdforaddiJj()ftD/nSQflrctJ toa:Jrjro>t rrotiorKIIpb_~tJ.
T1wu prdtll1RJarr~fo,.. I1yQ/lhtttitirprofruiortab 1ft dwpublic (ftl/~StefOnwIeo"'irtu..,
WK:aIWsa,,,,~ ",,~U'T'VI«$jarrnJ-tsatddfildTm. S-Co/dw pdtlinu.,OtwllftJrrappIicdJIIIltJ
pI'fI(w/ar Jm"'f{S CIIf' SI/llOlOU 6." tti/~Id tw corutdttrtd ill ITVM'WlIIJ' CIIrrT7IJprtICtkU.
CrnOUf'~"'Jht:rvtbtmlUtd 1hn:N';'-t. -PTOVIdt,- njtn toanylndMduai. ".rn. or plrysrdM",oU/itdloftW a
~~. n~ ,ndNrila/lIsllaJJvnsponslblttforag~d1l1d's1'OlltlTW""",_ g n/trrrdltJCU" dw wrrpJar
.-unum,,,n pfT1Vttk,- Gi",", the lo'lJI"l'atliOfU", procnCf!S _ populolwru DI:'7'O.U Corrado. II g lI",xnrood tItoI drtrT lIIiN
ffO Id~nflriahk~ItuprtfIIItkr", $OIIIt NsIJ anti IJw Itnn IIIGY ntCOmprzu tJ co/l«IlVt group'" lHht, aDa. "Child" 0'
-du~n 'J "WID ~ft,.tolltdmdllah..jrOfffmf(ftC]ltJarwghadok~ltCt.btiItKCf1It3.ldtrtdfo'lIII~lU
prtJcnbtd b.~'l"OIIfJ~""MUnmzt1(lft u:htduks.. T~fM$SIId1 Q;! "dkm" CIIIfli "pa4nl1" haw ftIN 1Hm.utibII' COfIJdH
t:r)II$ttkf'tl1""~~ahlt Ii",h "chl~r In tAt Int. -P(lf'l"1lI" Is IUtd thlVUg'-tl to dtsigntm 1M mditlit:Na/(s) Itgaily
,tJponJlb/~ fo, Ih~ child and Incwchs batir porrnu lU well CU" legal gucrn:iiaru.
Idtoif\'. lmmUIlIZOlum Jhould be pan o/comprth~1Wchildltood h~alth-<onprograms 10 ttISIITt t/rat childrm ofttiI.J
art IIP.IO-dof~ "'Itir '~Comffltndtd JchrdJlleJ. n,e de/;wrya/pnmarycort to mfanu. childrt1l, and odolucmu and roul/'"
;mmumzallon III COIIodo iJ dOlW In 0 VQI'I~ty ofS~fllng:.from p!ryJJciaru' oDicts to pub/ie-htttith clinla. Prtw:u provide,
and local heolth officiols should COOpt"'l~ 111 'he" ~fforls 10 twllrT high cowrogt ""llS in tht community /Q ach/nT and
momt"m th~ hlghtJI poJJlblt dtgf'tt ofCOmmlllllty pro/eCl/on Dgo"ut Vt:ICC",~.pff!WIt'oh/tdi$f!tuts,
On twhof(offllt collabo,olllt! groups. we QJIt jo, .VOl"filII cooptT'OIlOfI In Stmn"K '0 follow lheJe guukliMs jo, chlldhooo
ImmU1II;:atlfmpTtlICII(;f!J.
GUIDEUNES FOR CHILDHOOD
IMMUNIZATION PRACTICES
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Gum[ll~E I
1_."'au.... ""tTicuJ"_fdkn.~....iJ.hJl_
Page 3 0
1mmuru:t3u<ln Sl;:nlCCS should be resporwvt: 10 lhe n«ds ofpclI'allS :mel ctuldr=. When fC'J5Ibk:. PfOVldcrs should schedule
LlImlwtU:lIIl'ln :Ippomunents In cooJuncuon WIth appointments for other lIalth SCl"\1ees for ctuidrftt. lmrnwuzauon KlVlees.
wtIethcr pnbhc-hc3lth ChNCS or pIlYSICID.fU' offices. should be a\111lablc dUOJ\~ thc wecIc llrtd at hours that are convauent for
~p;lrcnl~ Semces ~hoold be .wllable on workutS da\'S. 3S well as dllJ'Ulg some other hours le.g. weekends, c-.=tngS.
carlyn'KlfTlln;s.orlunc:hhouni,
GmnEll~E2
TlD.! JII_'J k 1111 HniU7 W' IUUU'CUSIUY prntfluuUn 'Q 1111 r«np, Q{NCrinn.
While 3ppomlmenl $\~lems facilitalC Chilli: pl.ruung. and notd unnecessank'iong WIllIS fOl" c:luidrftt. 'ppomancru only syst=t
may aCI 35 h.:Imers 10 the n:g:lpl. ofVll.cclllCS. Children who .ppear on an unschedu.led bUIS fOl" vaccmauon shou!d. be
~Lcd. \\hen possible. Such children should be ~ptd1y and effielcnuy screened WIthout ~quU'lng other comprdtmslvt:
ltfaI1bgr,lCCS
1\ rehlblc Jc<:mon 10\~IC C3ll be bued exc:lu.sI\~1yon o.bc miormauon ehc:ncd from I parent.. and on the prcmda's
obscn'llUOll5;1ond Judgmau..bcul: dill cIuld's wel.lncss at the tIt1'Ie. At I l'TUIlIml.Im.. tlus 1D;1udc!
J;lolllll Ihc p3rml If the c:luld is well
oOseT'lln!!thcc:luid'sgc:nenlstl.teo.l·health
Policies al'ld protocols should bedevtloped .nd unplemcnted so Wt the adrrumsuaulXl of\lICCIl\C does not depend. on
lIIdMdu:l.l \\nlten Of'd£n or on • man! from I pnmary-<:aMprotldcr.
GUIDELl:-1E3
R..;"lt";I""__im".tUt~JD'YiusNt_U"tt~fulfJd
AD rooune ~htldhood LrtUnWlJZaUOllS. as recommended b..- NI\(.'I. :.houkl be (;(XI.Jlda'ed neccssarv mechcal Kn'XIf:S, As sudl,
they Snc>W<1 h: munood;lot no~e 10 paucnlS Wloer prtt\l1'lC14i 3nd temtonll health-ser\1C:e: S''Stems.
GUIDEUNE4
Prt1ritJU7 J",,,,,,, lise.JJ 1;WUc.1 uu:fIfUUUI IQ JcrU1ft.,. "Ufip v.eeUrn."ti.. wlrtlf~ l'IIor:iIfMtI eJriUr-.
EICh encounter \nth I hl211h-<.an: pn:Mder_ mdudm@.those thaI OCQJI' durtng bospttahzauon. IS an oppommtty 10 ft'lCW the
IDIlII\IlUl3IIOCl Sl;l,WS and If lI'lCbeau:d.ldmmtSlCl" Deeded \1ICCmCI. P!'n.'SICIIN~"booffer~ 10 m.&n1S I.IJId c:Inldren sbouJ.d
eormacr the ,rnm=uon staws It t:Va"I' 'I'Slt Illd offer unmUl1lUtl~ SCI"\'\eC U I l'Ol.IUne pan of!Nt can: 01" moounge
l~lII.:C~l lhe ;IopproflllllC publIC: be:llth 01" ~'SICWl cliruc:. Al eaeh !losplwldnuSSlDn the vaa:lN.UOD m:ord dxWd be
reYIt\'C".J. JnIJ hclOr~ Ol$dtarge from the hospital. cluldren should ~\'e the YaCCUlCl fOl" wtueh they uc: eligible by 1ge or
health ~UIlU; rite child's Cum:nl tmrrnInlZll.uon pro\lder should be llIiormcd lbout the vac:e= admuustered in bospltal.
HOWt:'.'CT, ,u~~cssNllmplc:mcn\luon TCqulres sl!!fllii=t unprot-emcnlS mKc:eplng n:eords ofimmwuzauOII histortes
{~,
GUID[ll~[ 5
""""~ '''QuIJ ,J,,«1t ptuorD;" ftttfuw1 tt'ntfJ .btHI, im".""ir.Juitm.
?rO'nUl.~ ":'",11<.1 ~-dUl:3le pal'elllS 111;10 eu!tunlh scnnu\'e W,,"". pn:ler:lbl\' In the:tr own ~gt'••bout the trnpCI'taDcc of
\"lCCtn:llll'n 'nc <.IISC3~~ \lICCmc:s prc-.~I. the recornrnerukd unmuruz:IUOrt schedules, the neoi lQ rc:<:etvt: vacclnCS It
recomm~r.J;~,1~~"S, JI'IU the: lmpon:tllee otbnll@lfl!!'the:trchlld's\;IoCCln3UOII=d lQ e:\'~' hcalth-care VIsit PlU'Crt1S shou1d be
cncour:l~C':' :,' IJlo:: n'SIlt'IIlSlbl1lt\' for cnsunn@th.1tlttc:vchlldeompicte5 the: full senc:s. Provllkn should answer III quesuons
parctlS lr"". ~-1'''' ~na lll'I)\lde ;Iopproprt:ltecduc:.3UOl'I m:ll,eTL3ls aI sWl:Ible: TC3dut@-\el'els.pre1mblvmtheparatlS'preferred
Apni:'; \I
CCDR \'01 23 (ACS-6) GUIDELINES FOR CHILDHOOD... Page 4
l~~r. PfO\ldcrs should f;mulww: Ihcm1c:hon ",m mfamlllll1Ol1 on lJIImunlDUon J'l"O'ldcd by the apPrOpnatr beaI1h
depanmo=nuuwrllull'lhrrsoun:cs
GUlDEUNE6
i+ffo-itkn JIo..,u iIlf_ /MI'DIfS in~ unru.JHHu 1M riJ.h..60Hjia II/..a:inD daN dciU it,.ncmc.
lrUOr1JI:Iuon p;unphIeu aboulrour.&Jleduldhood \'iJQ;U1C:S are a~b1e fromllDDlStneSofhealtb mmany~aDd me
t=1tone1..;I1d abo from lhIlC~ P.1cdwnc SocIety. Such l*DPb.IetI are bdpfuI in anno.-enng rnaDY <p::ttXm lha.l pete"
nay 1\;I\~:I.boulunmumzauon. PrU\'1dcn sbouki doeurnent m the medlcaI f'CIOCXd tha1 they ba~ uked the P'talIIlftbcy hau:
~'~andsh::lWdcnsurclhatausi.-ctorvmswenIOmy~WC"elPYen.
Pwl.lders dlouId. e:qWn ",heR aDd bovo'lO obUm mecbcal can: cfunn8 dayume and mgbaune m case ofan..:h_ C\~
folJo\\'1Il!l \'l1eemauon.
GUIDELINE 7
p",.,jdas Jh-'''r«fllfUtf_''''4"",,fNwilJ.JfolJilrK''/NedtrQltw,""~oN,.
There.1tl: len' few lI'Ue conInImdlcauons 10 ....ecuallOn afXUdins: to eunmt Canadian ~wdeline:s aDd provIdcn muat be'\Iiaf
oflhcm.A~ cand1uons that are nlM true eonnU1dlcauoru often results In the neailess deCanJ ofindieatecl WCl:ine:!J.
Muum.:ll a~b[c screenlng procedures for pn:cauuons aDd cootm.ndicauoru lIlclude .slcing questions to elicit a history of
possible ;Id\-ene events iollo.....Uli pnor VlIec:1N.\lons. ,md delemtlning my exISting preeaUUOltS or eonnmdicaUOll.l~
:J:::::~::;;;;;:p=.u"on.f~~:;:dvacc'~D"=~::..;'=
I \'l1ecmc:doK \-.cc:olkrwqllJjectlOD
I\rlapbylaetl(:rc:acUMIO\'KCUle
I conmll.lC:l.U _illnaswllhCll"
I """"'uM~""""""hM r.-
\\,tbout levef aIIWIIJCrobi.aI tbenpy
on\..lac:cDtpbueofiJ1aea
Pmnatuntyb-w"""'-
L J or fanuly tuslOry of~':'......"""""~=~~
OPT .\l'\iIph\ [lieue reaelion 10 pn:\'OUS dose Hypotoruc.hyporaponsl'o'C SLite HisIOl'y ofpemw:1S
0* ",thm48 hOW'Iofpnordoseof I
DPT ~eYa">_ 4O.So C ana- poor
IOfDPT
!fanulv 1uSUin' of.udden
~ death s}ndromc
ConnllslOO",thin.8houn:
olpnordoscofDPT I~umiv lustorv of oonvuWoru
. I
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~FDPr1?a:;:...OPV Inlceuon\\l.thl-llVorbousdJoldCGnUIe:t~· lfecdm@.\\llhIIIV .lIlUID1Crobl&lIherapyIQnunoddiaax:v state
fPV'==~= l I~ ;;;~~":;;~;:::=..::~... ~~:==l
rubella unmUlll2alU:ln In the lim .IIItimicz'obia Ibcrapy
tnme:lItel'"shouldllOlbeareuonlO
..-um1dert.mnlllal1clnof~) OIl""thHIV
ImmunodelictcllC)' S!.lte on-.peclflC allergy
Hib '1On' of Htb disease
HBV
lnfIucna An:lph\ Illl:t1C rc:Icuon to eglI
- AdlIpted from lhcCCJII«iKllflmmUfllnll/(JII G!l1d~. -Ilh ClbtlOll, 1993. For fUnher snCormatiOlloonsulllppupuitc
'IOI:Uonsofthe~UlOe.
I-Tbc,"-mtsorcoDliIl1U1SI~uprecauuOlUarenol:~bOnSbullbouldbe~'CODS~in
,~LbcbeDefitsandrisboC~IaUl&:ls:pecIfic\_lftbcbcDcfilJarebdie\."tdklOUl~tbe
nsbte 1D00000000orfonallDlr.l~.tbewccmesbouidbe_
GUIDELINES
PrtwMD'f Jlo_Ul.imitUun.u NCICiIur Uusj"M wIUdI. dUU 1# difiIM IIIIdwa- of-d ftP:.
A.'''llroble,"~UJliie;UcsthatllJOllnJWIXchildboodvacc:mc:seulbe~&ltbc:_\'llIit.sali=fymddfocuvel!"
Sorm\"X:anCSare~lnlcemt:anauonfonrw",itc:mlymorethanapetspwoml,.iaJecooamdocbl=n~
scpar-.telDlecuon.
GUIDELINE 9
P'rfIvitknJil_WDUlU.do• .u~tu••caq.uJ,"'~r«ertlDL
9.1 Data to be retorded in the child's rttord at tbe time o(vaccination
Foreadt\OlCCLllCadmuw~tbc:=umdalatobeteeordodintbc:chiid'.nlCOrdshouJdincludetbc:namcoflbc\'alX:me,tl
date IW\. mooth.aDdyear)and route ofldmuustrauoo. the name oflhe vacemelIlalDlfaeturer, the lot. numbef, and tbc:~
Indulleoflhepemxt adrnuuste:nns theVlOC1nC.
9.2 l'pdating and maintaining the penonal vaccination record
All prG\lders shoWd cncour:ll!e Ihe pamllS to mamtaLll a copy oftheir ehild'. pcnoaaI vaoeinat:icXJ. record card IUd present 1111
eadt hC;lIIh-<:a~ \15lt so Wit II can be updalOi Ira pa1=t fails 10 brm@;lchiId'.cud.theprtMdct.houldms~ thaI adequuc
uui:wm.:luon IS !I\'tn sotheparemcan update the card WIth the IIllmIl(s)ofthe vaocmc(a). thedatc:, thepn:l'Ylda"lUd the bellin'
9.3 Documentation for vaccines given by other providen
Pro>1Ocrs :ohoold f.:lc:l1Il.:lte the lDnlIla oCUlfomL:lU(X1 m die VlCCItIIUIX1 nlCOrd to ocha pro"1dcn IUd to .ppropr1IIlC Igc:nacs I
acoorc;lIIcc\\lIhlegtwuan.
Apnl :!S. 1998 11
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WbmJpl'O\'der\\hodoesDOtrouunel\·\~N1teort;;U"CIOrac:hlldlldmuus(cna\"a:lJ"Ietothl.tc:hlId.tbc:regu.W-pnl'Ylda­
sbauldbeul.lormed.
GUIDELINE 10
~JJoOJlu-u.aill~..s;q'~JIlIPUftfIriD·ftJu'NJc:cUIfIlimI,eawaUlfadJiude.,~
tl'KICinllfiDlI..
Pru\"locn shouJd lNIuu':lJn separate or C3n1).. reute\lIIb1e surnmomes of\¥:Clll.:luan records to EaaIitllte ass.eumcmof~
\\"dl as tne: KJcnufieJum and n:c:a1I ofduldn:n who nus.s appomtmmlS. In .ddiOQQ. unm=uan files sbouId be..xud
pcnochc:ail\. \\,dl tnaal\llm:cnbP.c:ed mto a separ.1lC tile. PfO\lden should indJeate IJI thetr rec:ords.. Ofmanappq:na~·
ldmtuieli place. .11 ~.-e:an: SCl"1c:es th.at each cluld 1'eCel\'eS \It order to facili1.lllC scheduhng \\'ldl othc- serYlCeS.
GUIDELINE 11
1+fr,iders sJoolIU,qHUf clinit::1J1ly si,,,ijiclJnllJdrnn: PWfn ftJl41win, "lJc:cUI~' pNHPlptly, lJ«:lUatdy, IUftl t:tImpktel
Prompt rcponUl@.ofac!\wue\'efWI folloWUl@. "C:<:lnlUon 11 cssenlUtl to msun: vaccine safety. allowlng for timely t:Il:Im:Ctive
ac:tton ,,11m ru:edcd. and to C:ODW1uaUy updalC mfonnauon~\~ nsk-bc:nc:fit and oontramdicauons.
Pfo\.\dcn; shouIdutSUUCt parmts to IDfonn themo(~ e\-enu; followmg vaccmauon. PrcMdcn shouIdreponall c:IWeaI1
sl@Dliic:ame\-enlStothekJcalpublic-hca!thaulboruy.rc:prdlmsolwbrthertbqbdic\lltheeventsarecausedby!bewc:cine
not. Pro\"ldcl"lI should fu1Jydocumcatthead\'e!"lIer.=t In the medical =uti attbelllDC oftbe e\UIloru soonuJlOUl.bIc
there:aru:r .\te:lc:b=uan\'lS1t,tnfortnalJODsbouidbelOlJ!ht~sc:noused\'eI"lIee\'UllSthatrna:yhaW;OIll:UmlC
fcikMUI;pn:"I'MKIS \"IQC:Ul;I.uoas.
GUIDELINE 12
~JJo_U'qwf"JJ.Cflsafl/_cdn~tlucuU.S'Cff ..irallUUlup~."tI~krUl.tio«
f'n1o"dcn should blow lht: local recpwancnlS for dlseue reporl1nf- Rcporunsof"ccme~blediseua is essawaJ fu
lbc Oll@.OLnie\'llluallDnoldleeffect1\1!nCSSof immuruzal10ll~ to l'acililllte public:-bcalth Ln\'eStipllDn olWCWlC fail,
aDd to lac:ditate aPPfOp'lll.te medical Lnvesupuon ofa c:bild's fa.L1UR to respond to a \'llCClnc IIppropn.1tely gi\'Cn.
GUIDELINE 13
PrrriJen sh_U"i/Jure t. "Pf11T111rlM~ ~MnJftH' "fKdn~ ",,,,,.,emDfL
Vacc:nes must be handled and stored as ra:cmmmdcd III manufac:tum-s· pac:bge mserts. The temperatures at which VMlClne
are Inn$noneG and sured shouJd be morutored duh· Vac.emcs must DOt be admmulered after thetr apuy dale
Prul1a:::"S .nouIdfqJOr1~ \\"a~.Ioss.;andUl\-enlOJVas~mib\·provlncLlJ. tantonalorloc:alpublic-bmlth
alXbon\l~'"
Pro\1dm sboWd be familiar W\th publtsbcd nauooal and local ~hnes lOr \-.cane stonge: and bardling. Pnnrxicn must
easure :Ntaln· offic:e statTdalgoaled to I\and!e \"&IX:UleS are also flJl\llJar W\th the (Ulddmes.
GUIDELINE 1.
i'rV'IiIiUJ Jh_Um.iN"in IIp-4HtIU. euily ,minobkprtllocou ", flU Wc.lioru ...ltne raaiIln",e~
ProvIoc:rs ~oJnufUStennl! \lIIc:c:ItICS should matntaLn I prntoool that. at a muumum. discuues die appropnate ....ccine dosage:.
\'llOt:m~ ~,mlraltldJClIllons. the rec:ommendcd SItes and tecluuques of\"C:<:lr\I: IIdmirustnluon. IS weU as possib1ead\'l::ne evenl
and th,,:; ~:ncrl!c:nc\· mano!!c:rnenl. The Cllt1ll.l:han Immwuz.auon Gwdc: and updates. along With pacbgc 1tISCIU. can serve as
rd'em:1;~, lilr the dc\~lopmenl ofprotocols. Such protocols should SPC:C:lf..· the noeesJary" emergency equipment. drugs
ClllCiuc.;::;. ~gel, and pcrsonnel to man&!!ll safel\" and c:ompelcntlv 11m· medical emer'!mc:y amlnl! aficr admiDistn.uon of.
''llCCUIC \11 pnn1<krs should be f.mthar ....lIh thec:oruent of these protocols. theu" location. and bow 10 follow them.
GUIDELINE IS
Pro".fiu, .h_Ub~propalrrr"u.rtl""J ",.ir"ain""Koi", ~Jllouimt,q"niUr~OlrnrrtimmJlItiurioa~
V&CC:Ir.. ::lUSt be ~lnISIcredonIv boo· properi\ ~lrlai pcnons \\110 arc~ as cpWlflCd ItI their speaf~ Junsdle:uon
Tn.=r.~ ~...J.lft£outII: cduc:allon should be bucdon = !Wdehnesand~uonsofNACI ~pvvttlQIJand
lemte:':_. ;:llm~tm:s ot hmlth. the uuLdchnc:s lOr Childhood lmrn=uon Pr::lc:uces. and other sources of informatIOn on
April:·:: 1<)(l8
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GUIDEUNE 16
~J"_JJopuM6.tNldiIrJJ'JiDrL
Alraelang J~"Slem should ~lerenundc:rJ ofupcorrung "aCCIJ1llUODS IJ well All JeCIIliJ forchildrcu WholRl overdue for thel
\-.eell1IUOOJ. A s~"StmImay be manual or aUlOma!ed. and may IIlCludc maUed or telephone mc:JSI@a.AlI proVldcn:~
,d=.ufy. fur adWuonai Ultensl\~ nebng. eifons. cluJdren C(lftJldefM II lush ruk for £ailing lO oomp/ete &he unlDUQa;Wan sen
IXlsdlcduJe(c.g. duIdrc:o wboNn thc:lrsc:ncs late orduldren who fall behmd scbIdukt
As In added~~ sboWd mc:oungzlhl: dc\'dopmcD1 oC. aod coopcrwoa. W11h. a~w provmcW &lid
~ unmuruDl.im ncking$)'RcrD-
GUIDELINE 17
AIAiiu JlftHdli M ClHlIiIN::uIi;".1J itrwIlUIiuIUm diniG 10 uuu t"~ ,1IIdiIy ofimmlUliulitm r«INIh _li.uas
~iuWmm~kYds.
la b«b pubbe and pm.'Ite JeCtOn,ID ludit of ID:IlDImIalKm~ sbouid Ulcludc &ucsJmcIII olall or llamiomsamplc of
iD::mmuzal:lanl'OXJrdJlOAlIJeSSIbccpa!ilyofdoc:ummwJon._to~Ihl:IDIDIUIIIZalJOD~Ind(e.1-1hl:
~of2-year-olddWdn::o.wbo~l.IIHO-date).Tbcraullscllhc.1.dilsboWdbecbJc:ussodbyP"MdcnQputol~
~ cp!Jr.' Is.surtIX:C revleWS. and used to devdop JGIutJOm 10 the probiam: Jdawficd.
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Codo _
SCript for inttial contact (2-3 minutes)
Hello. my name is Cathy O'Keefe and I am 8 graduate student at Memorial University of
Newfoundland. Community Health. My research is related to ImmuniZation. Does your
office provtie childhood immunizations. Ves No
(If yes) I would like to malee an appointment to visit your office for 10-15 minutes in the
next monttJ or $0. When would be the most convenient date and time for you.
Dote: _
Time: _
If no or not sure if Or will be able
Would it be o'kay for me to caJl back later?
f wiR leave my number if there is any change: 753-1349 (home number)
Script for Second vialt: (5-10 minutes)
Helle you had any questions orconcerns about the information Jeft on the ~ast visit?
On Storage and Handling:
On Documentation:
Ifconsent was given. may' measure your refrigerator temperature ? _
Do you have any other comments:
Appendu I
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REPORT OF A VACCINE-ASSOCIATED
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SUPPLEf..1ENTARY INFORMATION
INSTRUCTlONS FOR COMPLE11NG REPORT OF A VACaNE-ASSOCIATm ADYERSE EVENT
1. PleaseusedarkrKlWhetl~tomllCllT1prollelegtJilityolcopies.
2. RepoItonlyevenrswhic:h l'IaYe a IempcwaI association wilh a vaccine andwhic:hcarnor:beat1ltluled to co-existing
conditionS. A~~ doM not need to be prown,.-1d aubrntntng • report does not Imply eaauIItY-
3. Events marbtd wilh an asterisk (oJ m.JSt be diagnosed by a pt1ysician. Supply relevant details in the SUPPLEMENTARY
INFORMATION bole.
4. Record nt8rvaI be!W8en vaccine adn'ftstralian and onset of each ...... in rr*luIes. hour3 or days.
S. Provide relevara infDmIalion. when appropriate, in 1he SlJPPI...B,tEN' II'#ORMATlON bolt. tnc:l.Ides dlMIlIs ollMlnts
diagW)Sed by pIT,'sici8n (see 3 aboW), restAts at~ cr IabofalCIfy tests. hospital~ and diachaII;Je~
where • vaccinee Is hospitalised because 01 a vacc:in&-associ adverse ....... "appropriaa, and pretened.
of original records may be Slbmitted.
6. PmIIIde details of medical histoty that 8l1l relevant to the adverse event(s) reported. Examples nctude a history of allergies
in vaccnee. previous advene event(s), and conc::urnlnI ilnesses whiCh trI3!f be associated wit! the ctJmlI'lt adverse event(s
TO.~ rNlE*:AL.HEAI.Jlt Clf"FICP: AECClIIIll&IDrAllONS FOR FU'I'1ltIR.....-zATlON
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